JP2009537545A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009537545A5 JP2009537545A5 JP2009511067A JP2009511067A JP2009537545A5 JP 2009537545 A5 JP2009537545 A5 JP 2009537545A5 JP 2009511067 A JP2009511067 A JP 2009511067A JP 2009511067 A JP2009511067 A JP 2009511067A JP 2009537545 A5 JP2009537545 A5 JP 2009537545A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- methyl
- pyrazol
- amino
- ethoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 C 1-6 alkylureyl Chemical group 0.000 claims description 534
- 150000001875 compounds Chemical class 0.000 claims description 100
- 125000000217 alkyl group Chemical group 0.000 claims description 77
- 229910052736 halogen Inorganic materials 0.000 claims description 60
- 150000002367 halogens Chemical class 0.000 claims description 60
- 125000001424 substituent group Chemical group 0.000 claims description 58
- 125000003545 alkoxy group Chemical group 0.000 claims description 50
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 43
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 40
- 125000000623 heterocyclic group Chemical group 0.000 claims description 38
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 37
- 125000001072 heteroaryl group Chemical group 0.000 claims description 37
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 36
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 36
- 125000002252 acyl group Chemical group 0.000 claims description 36
- 125000005431 alkyl carboxamide group Chemical group 0.000 claims description 34
- 229910052799 carbon Inorganic materials 0.000 claims description 32
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 32
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 32
- 229910052739 hydrogen Inorganic materials 0.000 claims description 32
- 125000004422 alkyl sulphonamide group Chemical group 0.000 claims description 28
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 26
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 26
- 150000001408 amides Chemical class 0.000 claims description 24
- 150000003857 carboxamides Chemical class 0.000 claims description 24
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims description 23
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims description 22
- 125000005432 dialkylcarboxamide group Chemical group 0.000 claims description 22
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 22
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims description 21
- 125000004423 acyloxy group Chemical group 0.000 claims description 20
- 125000004043 oxo group Chemical group O=* 0.000 claims description 20
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 19
- 125000004738 (C1-C6) alkyl sulfinyl group Chemical group 0.000 claims description 18
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims description 18
- 125000004995 haloalkylthio group Chemical group 0.000 claims description 18
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 18
- 125000003396 thiol group Chemical class [H]S* 0.000 claims description 16
- 125000004749 (C1-C6) haloalkylsulfinyl group Chemical group 0.000 claims description 14
- 125000004741 (C1-C6) haloalkylsulfonyl group Chemical group 0.000 claims description 14
- 125000005277 alkyl imino group Chemical group 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 12
- 208000035475 disorder Diseases 0.000 claims description 12
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 11
- 125000003118 aryl group Chemical group 0.000 claims description 10
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 10
- 125000005363 dialkylsulfonamide group Chemical group 0.000 claims description 10
- 229910052760 oxygen Inorganic materials 0.000 claims description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims description 10
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 10
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims description 9
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims description 8
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 claims description 8
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims description 8
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 8
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims description 8
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 8
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 claims description 8
- 125000002947 alkylene group Chemical group 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 8
- 229940124530 sulfonamide Drugs 0.000 claims description 8
- 150000003456 sulfonamides Chemical class 0.000 claims description 8
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims description 7
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 7
- 125000004414 alkyl thio group Chemical group 0.000 claims description 7
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 6
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 claims description 5
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 claims description 5
- 206010020772 Hypertension Diseases 0.000 claims description 5
- 208000002193 Pain Diseases 0.000 claims description 5
- 208000006673 asthma Diseases 0.000 claims description 5
- 206010012601 diabetes mellitus Diseases 0.000 claims description 5
- 206010036807 progressive multifocal leukoencephalopathy Diseases 0.000 claims description 5
- 208000019116 sleep disease Diseases 0.000 claims description 5
- 208000010110 spontaneous platelet aggregation Diseases 0.000 claims description 5
- 125000004768 (C1-C4) alkylsulfinyl group Chemical group 0.000 claims description 4
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims description 4
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims description 4
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims description 4
- 125000004771 (C1-C4) haloalkylsulfinyl group Chemical group 0.000 claims description 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 4
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims description 4
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims description 4
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims description 4
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims description 4
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 claims description 4
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 claims description 4
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 claims description 4
- IFFOFTIDKDHIMA-UHFFFAOYSA-N 4-(2-aminoethoxy)-3-(4-bromo-2-methylpyrazol-3-yl)aniline Chemical compound CN1N=CC(Br)=C1C1=CC(N)=CC=C1OCCN IFFOFTIDKDHIMA-UHFFFAOYSA-N 0.000 claims description 4
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims description 4
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims description 4
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 125000004863 4-trifluoromethoxyphenyl group Chemical group [H]C1=C([H])C(OC(F)(F)F)=C([H])C([H])=C1* 0.000 claims description 4
- BNMPIJWVMVNSRD-UHFFFAOYSA-N 5-methyl-1,2-oxazole-3-carboxylic acid Chemical compound CC1=CC(C(O)=O)=NO1 BNMPIJWVMVNSRD-UHFFFAOYSA-N 0.000 claims description 4
- ULVHFGJIXUNKHT-UHFFFAOYSA-N benzyl n-[2-[4-[(3-methoxybenzoyl)amino]-2-(2-methylpyrazol-3-yl)phenoxy]ethyl]carbamate Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OCCNC(=O)OCC=3C=CC=CC=3)=CC=2)C=2N(N=CC=2)C)=C1 ULVHFGJIXUNKHT-UHFFFAOYSA-N 0.000 claims description 4
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 claims description 4
- VIYYWJRDWMOSLY-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-oxo-1h-pyridine-3-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C(NC=CC=2)=O)=CC=C1OCCN VIYYWJRDWMOSLY-UHFFFAOYSA-N 0.000 claims description 4
- DNBFJHOEMAEGED-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-5-methyl-1h-pyrazole-3-carboxamide Chemical compound N1C(C)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=N1 DNBFJHOEMAEGED-UHFFFAOYSA-N 0.000 claims description 4
- GFQLNHJVERENQL-LJQANCHMSA-N n-[4-[(2s)-2-amino-2-cyclohexylethoxy]-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide Chemical compound O1C(C)=CC(C(=O)NC=2C=C(C(OC[C@@H](N)C3CCCCC3)=CC=2)C=2N(N=CC=2Cl)C)=N1 GFQLNHJVERENQL-LJQANCHMSA-N 0.000 claims description 4
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims description 4
- 239000012453 solvate Substances 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 238000002560 therapeutic procedure Methods 0.000 claims description 3
- ICCWSABFQMUEBG-FQEVSTJZSA-N (2s)-n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-methoxy-2-phenylacetamide Chemical compound O=C([C@@H](OC)C=1C=CC=CC=1)NC(C=1)=CC=C(OCCN)C=1C1=CC=NN1C ICCWSABFQMUEBG-FQEVSTJZSA-N 0.000 claims description 2
- XNYJBOQEGQWPQB-AWEZNQCLSA-N (2s)-n-[4-(2-aminoethoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-2-(methoxymethyl)pyrrolidine-1-carboxamide Chemical compound COC[C@@H]1CCCN1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Br)C)=C1 XNYJBOQEGQWPQB-AWEZNQCLSA-N 0.000 claims description 2
- PHUAZBNPLIJXHI-UHFFFAOYSA-N (4-nitrophenyl) n-[2-[4-[(3-methoxybenzoyl)amino]-2-(2-methylpyrazol-3-yl)phenoxy]ethyl]carbamate Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OCCNC(=O)OC=3C=CC(=CC=3)[N+]([O-])=O)=CC=2)C=2N(N=CC=2)C)=C1 PHUAZBNPLIJXHI-UHFFFAOYSA-N 0.000 claims description 2
- YQBYHHOBQDJTLY-UHFFFAOYSA-N 1-[2-[3-[(3-methoxybenzoyl)amino]-2-(2-methylpyrazol-3-yl)phenoxy]ethylcarbamoyloxy]ethyl acetate Chemical compound COC1=CC=CC(C(=O)NC=2C(=C(OCCNC(=O)OC(C)OC(C)=O)C=CC=2)C=2N(N=CC=2)C)=C1 YQBYHHOBQDJTLY-UHFFFAOYSA-N 0.000 claims description 2
- 125000004562 2,3-dihydroindol-1-yl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 claims description 2
- 125000004463 2,4-dimethyl-thiazol-5-yl group Chemical group CC=1SC(=C(N1)C)* 0.000 claims description 2
- XLDKIOPREGPAGK-UHFFFAOYSA-N 2-(dimethylamino)ethyl n-[2-[4-[(3-methoxybenzoyl)amino]-2-(2-methylpyrazol-3-yl)phenoxy]ethyl]carbamate Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OCCNC(=O)OCCN(C)C)=CC=2)C=2N(N=CC=2)C)=C1 XLDKIOPREGPAGK-UHFFFAOYSA-N 0.000 claims description 2
- XQDFERFPTOMFME-UHFFFAOYSA-N 2-chloroethyl n-[2-[4-[(3-methoxybenzoyl)amino]-2-(2-methylpyrazol-3-yl)phenoxy]ethyl]carbamate Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OCCNC(=O)OCCCl)=CC=2)C=2N(N=CC=2)C)=C1 XQDFERFPTOMFME-UHFFFAOYSA-N 0.000 claims description 2
- VFMGOJUUTAPPDA-UHFFFAOYSA-N 2-ethyl-5-methylpyrazole-3-carboxylic acid Chemical compound CCN1N=C(C)C=C1C(O)=O VFMGOJUUTAPPDA-UHFFFAOYSA-N 0.000 claims description 2
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
- PYCFLCQAJFEELT-UHFFFAOYSA-N 2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carboxylic acid Chemical compound O1C(C(F)(F)F)=C(C(=O)O)N=C1C1=CC=CC=C1 PYCFLCQAJFEELT-UHFFFAOYSA-N 0.000 claims description 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
- XZZQSPCYHXMCPD-UHFFFAOYSA-N 4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)aniline Chemical compound CN1N=CC=C1C1=CC(N)=CC=C1OCCN XZZQSPCYHXMCPD-UHFFFAOYSA-N 0.000 claims description 2
- GGYCYUOOEVAITK-UHFFFAOYSA-N 4-(2-methoxyphenyl)piperazine-1-carboxylic acid Chemical compound COC1=CC=CC=C1N1CCN(C(O)=O)CC1 GGYCYUOOEVAITK-UHFFFAOYSA-N 0.000 claims description 2
- FRIRBHKMNMAHAB-UHFFFAOYSA-N 4-(4-methoxyphenyl)piperazine-1-carboxylic acid Chemical compound C1=CC(OC)=CC=C1N1CCN(C(O)=O)CC1 FRIRBHKMNMAHAB-UHFFFAOYSA-N 0.000 claims description 2
- UAFNWTXWPGYEJN-UHFFFAOYSA-N 4-acetamido-n-[4-(2-amino-2-methylpropoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]benzamide Chemical compound C1=CC(NC(=O)C)=CC=C1C(=O)NC1=CC=C(OCC(C)(C)N)C(C=2N(N=CC=2Br)C)=C1 UAFNWTXWPGYEJN-UHFFFAOYSA-N 0.000 claims description 2
- ABUPYBBLLDSUMF-UHFFFAOYSA-N 4-chloro-1-ethylpyrazole-3-carboxylic acid Chemical compound CCN1C=C(Cl)C(C(O)=O)=N1 ABUPYBBLLDSUMF-UHFFFAOYSA-N 0.000 claims description 2
- DZFLXQKMGDLGCP-UHFFFAOYSA-N 4-chloro-2,3-dihydroindole-1-carboxylic acid Chemical compound C1=CC=C(Cl)C2=C1N(C(=O)O)CC2 DZFLXQKMGDLGCP-UHFFFAOYSA-N 0.000 claims description 2
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 2
- OXCDTOALSNODSS-UHFFFAOYSA-N 5-bromo-2,3-dihydroindole-1-carboxylic acid Chemical compound BrC1=CC=C2N(C(=O)O)CCC2=C1 OXCDTOALSNODSS-UHFFFAOYSA-N 0.000 claims description 2
- AWNMURUHZNMHCF-UHFFFAOYSA-N 5-chloro-2,3-dihydroindole-1-carboxylic acid Chemical compound ClC1=CC=C2N(C(=O)O)CCC2=C1 AWNMURUHZNMHCF-UHFFFAOYSA-N 0.000 claims description 2
- NURNFMNHTHXTDS-UHFFFAOYSA-N 5-methyl-2-(trifluoromethyl)furan-3-carboxylic acid Chemical compound CC1=CC(C(O)=O)=C(C(F)(F)F)O1 NURNFMNHTHXTDS-UHFFFAOYSA-N 0.000 claims description 2
- LDZKAHXTEFCZET-UHFFFAOYSA-N 6-acetamido-n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]pyridine-3-carboxamide Chemical compound C1=NC(NC(=O)C)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 LDZKAHXTEFCZET-UHFFFAOYSA-N 0.000 claims description 2
- LGCPBGXRIGIBCI-UHFFFAOYSA-N 6-chloro-2,3-dihydroindole-1-carboxylic acid Chemical compound C1=C(Cl)C=C2N(C(=O)O)CCC2=C1 LGCPBGXRIGIBCI-UHFFFAOYSA-N 0.000 claims description 2
- GIFSROMQVPUQFK-UHFFFAOYSA-N 6-oxo-1h-pyridazine-3-carboxylic acid Chemical compound OC(=O)C1=CC=C(O)N=N1 GIFSROMQVPUQFK-UHFFFAOYSA-N 0.000 claims description 2
- VOAFGTBETRJDPU-UHFFFAOYSA-N 8-methoxy-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid Chemical compound C1CC(C(O)=O)CC2=C1C=CC=C2OC VOAFGTBETRJDPU-UHFFFAOYSA-N 0.000 claims description 2
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 claims description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 2
- QRKPPWPLSQRGSU-UHFFFAOYSA-N diazepine-1-carboxylic acid Chemical compound OC(=O)N1C=CC=CC=N1 QRKPPWPLSQRGSU-UHFFFAOYSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- OQNMWDCXWFZPQN-UHFFFAOYSA-N ethyl n-[2-[4-[(3-methoxybenzoyl)amino]-2-(2-methylpyrazol-3-yl)phenoxy]ethyl]carbamate Chemical compound C1=C(C=2N(N=CC=2)C)C(OCCNC(=O)OCC)=CC=C1NC(=O)C1=CC=CC(OC)=C1 OQNMWDCXWFZPQN-UHFFFAOYSA-N 0.000 claims description 2
- 125000002249 indol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([*])=C([H])C2=C1[H] 0.000 claims description 2
- 125000000814 indol-3-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C([*])C2=C1[H] 0.000 claims description 2
- 125000004499 isoxazol-5-yl group Chemical group O1N=CC=C1* 0.000 claims description 2
- WSSAJDMPGWLPOX-UHFFFAOYSA-N n-[4-(2-acetamidoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OCCNC(C)=O)=CC=2)C=2N(N=CC=2)C)=C1 WSSAJDMPGWLPOX-UHFFFAOYSA-N 0.000 claims description 2
- LYJFXIMPBZYCQW-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(4-chlorophenyl)acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C=CC(Cl)=CC=2)=CC=C1OCC(C)(C)N LYJFXIMPBZYCQW-UHFFFAOYSA-N 0.000 claims description 2
- AVTBWNVWENEFTI-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-(trifluoromethoxy)benzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=C(OC(F)(F)F)C=CC=2)=CC=C1OCC(C)(C)N AVTBWNVWENEFTI-UHFFFAOYSA-N 0.000 claims description 2
- YCLVAIJCMXHUEK-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-(trifluoromethyl)benzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=C(C=CC=2)C(F)(F)F)=CC=C1OCC(C)(C)N YCLVAIJCMXHUEK-UHFFFAOYSA-N 0.000 claims description 2
- MOYJCYCNCRMRQL-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-bromobenzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=C(Br)C=CC=2)=CC=C1OCC(C)(C)N MOYJCYCNCRMRQL-UHFFFAOYSA-N 0.000 claims description 2
- VUUIBLCZZJGUEG-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-(trifluoromethyl)benzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=CC(=CC=2)C(F)(F)F)=CC=C1OCC(C)(C)N VUUIBLCZZJGUEG-UHFFFAOYSA-N 0.000 claims description 2
- UDBUAOHBGVFGDU-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-chlorobenzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=CC(Cl)=CC=2)=CC=C1OCC(C)(C)N UDBUAOHBGVFGDU-UHFFFAOYSA-N 0.000 claims description 2
- JTXDXZCMEIWSNZ-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-2-fluorobenzamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)C=2C(=CC=CC=2)F)=CC=C1OCC(C)(C)N JTXDXZCMEIWSNZ-UHFFFAOYSA-N 0.000 claims description 2
- PWJUCFDVHUJDRU-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-2-methoxybenzamide Chemical compound COC1=CC=CC=C1C(=O)NC1=CC=C(OCC(C)(C)N)C(C=2N(N=CC=2Br)C)=C1 PWJUCFDVHUJDRU-UHFFFAOYSA-N 0.000 claims description 2
- ZJKDGFMYQOPUSO-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-2-phenylacetamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)CC=2C=CC=CC=2)=CC=C1OCC(C)(C)N ZJKDGFMYQOPUSO-UHFFFAOYSA-N 0.000 claims description 2
- LCSDRHXHFLNXHG-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-3-(trifluoromethoxy)benzamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)C=2C=C(OC(F)(F)F)C=CC=2)=CC=C1OCC(C)(C)N LCSDRHXHFLNXHG-UHFFFAOYSA-N 0.000 claims description 2
- KPHDIETZOQVVAY-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-3-(trifluoromethyl)benzamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)C=2C=C(C=CC=2)C(F)(F)F)=CC=C1OCC(C)(C)N KPHDIETZOQVVAY-UHFFFAOYSA-N 0.000 claims description 2
- WIJODGCZQDRYGC-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-3-bromobenzamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)C=2C=C(Br)C=CC=2)=CC=C1OCC(C)(C)N WIJODGCZQDRYGC-UHFFFAOYSA-N 0.000 claims description 2
- FYHKURDADAJVHU-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-3-chlorobenzamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)C=2C=C(Cl)C=CC=2)=CC=C1OCC(C)(C)N FYHKURDADAJVHU-UHFFFAOYSA-N 0.000 claims description 2
- GXKYKWZRHCZJCI-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-3-fluorobenzamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)C=2C=C(F)C=CC=2)=CC=C1OCC(C)(C)N GXKYKWZRHCZJCI-UHFFFAOYSA-N 0.000 claims description 2
- HJRAKILDNNCZQD-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OCC(C)(C)N)=CC=2)C=2N(N=CC=2Br)C)=C1 HJRAKILDNNCZQD-UHFFFAOYSA-N 0.000 claims description 2
- KBBSZBONYUEUAK-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-4-(trifluoromethyl)benzamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)C=2C=CC(=CC=2)C(F)(F)F)=CC=C1OCC(C)(C)N KBBSZBONYUEUAK-UHFFFAOYSA-N 0.000 claims description 2
- QDLQOPUSLVPDKS-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-4-chlorobenzamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)C=2C=CC(Cl)=CC=2)=CC=C1OCC(C)(C)N QDLQOPUSLVPDKS-UHFFFAOYSA-N 0.000 claims description 2
- XIIYDDUNSHEPLS-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-4-fluorobenzamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)C=2C=CC(F)=CC=2)=CC=C1OCC(C)(C)N XIIYDDUNSHEPLS-UHFFFAOYSA-N 0.000 claims description 2
- HPYJJGYEFFSBKH-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]benzamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)C=2C=CC=CC=2)=CC=C1OCC(C)(C)N HPYJJGYEFFSBKH-UHFFFAOYSA-N 0.000 claims description 2
- ZOPKKGOLNAHFQX-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-(trifluoromethyl)benzamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=C(C=CC=2)C(F)(F)F)=CC=C1OCC(C)(C)N ZOPKKGOLNAHFQX-UHFFFAOYSA-N 0.000 claims description 2
- XCICWOGWXMXSTI-UHFFFAOYSA-N n-[4-(2-amino-2-oxoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-(trifluoromethyl)benzamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=C(C=CC=2)C(F)(F)F)=CC=C1OCC(N)=O XCICWOGWXMXSTI-UHFFFAOYSA-N 0.000 claims description 2
- JDJSWUHSQXZIGD-UHFFFAOYSA-N n-[4-(2-amino-2-oxoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OCC(N)=O)=CC=2)C=2N(N=CC=2Cl)C)=C1 JDJSWUHSQXZIGD-UHFFFAOYSA-N 0.000 claims description 2
- ZJRLWVGNHAAAMD-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-1,2-oxazole-5-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2ON=CC=2)=CC=C1OCCN ZJRLWVGNHAAAMD-UHFFFAOYSA-N 0.000 claims description 2
- FPPWKHFAFJQFTM-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-1,3-benzodioxole-5-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=C3OCOC3=CC=2)=CC=C1OCCN FPPWKHFAFJQFTM-UHFFFAOYSA-N 0.000 claims description 2
- RIJSXMYNAFYJCY-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-1,3-dihydroisoindole-2-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)N2CC3=CC=CC=C3C2)=CC=C1OCCN RIJSXMYNAFYJCY-UHFFFAOYSA-N 0.000 claims description 2
- WUSWZZFXACNETI-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-1,3-thiazole-4-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2N=CSC=2)=CC=C1OCCN WUSWZZFXACNETI-UHFFFAOYSA-N 0.000 claims description 2
- XDWZTFHVDLWFQW-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-1-(4-chlorophenyl)-5-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C2=C(N(N=C2)C=2C=CC(Cl)=CC=2)C(F)(F)F)=CC=C1OCCN XDWZTFHVDLWFQW-UHFFFAOYSA-N 0.000 claims description 2
- UGKXZMYHASHYET-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-1-methyl-5-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C2=C(N(C)N=C2)C(F)(F)F)=CC=C1OCCN UGKXZMYHASHYET-UHFFFAOYSA-N 0.000 claims description 2
- AZCZPROAXJOBII-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-1-methylpyrrole-2-carboxamide Chemical compound CN1C=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 AZCZPROAXJOBII-UHFFFAOYSA-N 0.000 claims description 2
- AMQNEOILPADQNM-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-1-phenyl-5-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C2=C(N(N=C2)C=2C=CC=CC=2)C(F)(F)F)=CC=C1OCCN AMQNEOILPADQNM-UHFFFAOYSA-N 0.000 claims description 2
- GSBUUDLTEVIISE-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-1-tert-butyl-5-methylpyrazole-3-carboxamide Chemical compound CC(C)(C)N1C(C)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=N1 GSBUUDLTEVIISE-UHFFFAOYSA-N 0.000 claims description 2
- WCRSNMYFMDHPEC-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-1h-imidazole-5-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2N=CNC=2)=CC=C1OCCN WCRSNMYFMDHPEC-UHFFFAOYSA-N 0.000 claims description 2
- RJLFEBWIEJNITD-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2,2-difluoro-1,3-benzodioxole-4-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=3OC(F)(F)OC=3C=CC=2)=CC=C1OCCN RJLFEBWIEJNITD-UHFFFAOYSA-N 0.000 claims description 2
- DAAVZIFCCBAPMG-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2,2-difluoro-1,3-benzodioxole-5-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=C3OC(F)(F)OC3=CC=2)=CC=C1OCCN DAAVZIFCCBAPMG-UHFFFAOYSA-N 0.000 claims description 2
- RJFQBEOFHFXBTI-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2,2-dimethyl-3h-1-benzofuran-7-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=3OC(C)(C)CC=3C=CC=2)=CC=C1OCCN RJFQBEOFHFXBTI-UHFFFAOYSA-N 0.000 claims description 2
- LJJFVXUDWKWXLN-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2,3-dihydroindole-1-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)N2C3=CC=CC=C3CC2)=CC=C1OCCN LJJFVXUDWKWXLN-UHFFFAOYSA-N 0.000 claims description 2
- DWSWYWRXPLCQHH-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2,4-difluorobenzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C(=CC(F)=CC=2)F)=CC=C1OCCN DWSWYWRXPLCQHH-UHFFFAOYSA-N 0.000 claims description 2
- HPYICDXIFJYLDF-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2,5-dichlorothiophene-3-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C2=C(SC(Cl)=C2)Cl)=CC=C1OCCN HPYICDXIFJYLDF-UHFFFAOYSA-N 0.000 claims description 2
- UHTURQSOKRQPNR-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2,5-dimethylfuran-3-carboxamide Chemical compound O1C(C)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1C UHTURQSOKRQPNR-UHFFFAOYSA-N 0.000 claims description 2
- HHYPXZJKWLJIMZ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2,5-dimethylpyrazole-3-carboxamide Chemical compound CN1N=C(C)C=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 HHYPXZJKWLJIMZ-UHFFFAOYSA-N 0.000 claims description 2
- PFDNARIVCIHFQB-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2,6-difluoro-4-methoxybenzamide Chemical compound FC1=CC(OC)=CC(F)=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 PFDNARIVCIHFQB-UHFFFAOYSA-N 0.000 claims description 2
- XBDXDQYWJWMQNW-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2,6-difluorobenzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C(=CC=CC=2F)F)=CC=C1OCCN XBDXDQYWJWMQNW-UHFFFAOYSA-N 0.000 claims description 2
- MRMWAKSZNMTJMN-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2,6-dimethoxypyridine-3-carboxamide Chemical compound COC1=NC(OC)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 MRMWAKSZNMTJMN-UHFFFAOYSA-N 0.000 claims description 2
- NCHJLMUBFJHLDR-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(1,2-benzoxazol-3-yl)acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C3=CC=CC=C3ON=2)=CC=C1OCCN NCHJLMUBFJHLDR-UHFFFAOYSA-N 0.000 claims description 2
- ZHPCJXRSPJIASV-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(1,3-benzodioxol-5-yl)acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C=C3OCOC3=CC=2)=CC=C1OCCN ZHPCJXRSPJIASV-UHFFFAOYSA-N 0.000 claims description 2
- CERADNQVGCBIDE-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(1h-indol-3-yl)acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C3=CC=CC=C3NC=2)=CC=C1OCCN CERADNQVGCBIDE-UHFFFAOYSA-N 0.000 claims description 2
- NWMZTHOIYXZXIJ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(2,3-dimethoxyphenyl)acetamide Chemical compound COC1=CC=CC(CC(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1OC NWMZTHOIYXZXIJ-UHFFFAOYSA-N 0.000 claims description 2
- KFBOWQXZPWNFBH-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(2,4-difluorophenyl)acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C(=CC(F)=CC=2)F)=CC=C1OCCN KFBOWQXZPWNFBH-UHFFFAOYSA-N 0.000 claims description 2
- JLVURAFMPDZDFA-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(2,6-difluorophenyl)acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C(=CC=CC=2F)F)=CC=C1OCCN JLVURAFMPDZDFA-UHFFFAOYSA-N 0.000 claims description 2
- REXWKOVRTDVHSB-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(2-chlorophenyl)acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C(=CC=CC=2)Cl)=CC=C1OCCN REXWKOVRTDVHSB-UHFFFAOYSA-N 0.000 claims description 2
- UFFMRQNANHAOEN-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(2-ethoxyphenyl)acetamide Chemical compound CCOC1=CC=CC=C1CC(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 UFFMRQNANHAOEN-UHFFFAOYSA-N 0.000 claims description 2
- YCHFMPPFOQMBKT-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(2-fluorophenyl)acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C(=CC=CC=2)F)=CC=C1OCCN YCHFMPPFOQMBKT-UHFFFAOYSA-N 0.000 claims description 2
- GYTCTHFEBWGPMO-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(2-methylphenyl)acetamide Chemical compound CC1=CC=CC=C1CC(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 GYTCTHFEBWGPMO-UHFFFAOYSA-N 0.000 claims description 2
- HIWVASAKZRQOCG-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(3,4-dichlorophenyl)-2-methoxyacetamide Chemical compound C=1C=C(Cl)C(Cl)=CC=1C(OC)C(=O)NC(C=1)=CC=C(OCCN)C=1C1=CC=NN1C HIWVASAKZRQOCG-UHFFFAOYSA-N 0.000 claims description 2
- RBWVFTDYQYLDCC-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(3,4-difluorophenyl)acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C=C(F)C(F)=CC=2)=CC=C1OCCN RBWVFTDYQYLDCC-UHFFFAOYSA-N 0.000 claims description 2
- YTFBWYDVBRAKJU-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(3,5-dimethylpyrazol-1-yl)acetamide Chemical compound N1=C(C)C=C(C)N1CC(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 YTFBWYDVBRAKJU-UHFFFAOYSA-N 0.000 claims description 2
- VMEGQVZWNVXHRD-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(3-bicyclo[2.2.1]heptanyl)acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC2C3CCC(C3)C2)=CC=C1OCCN VMEGQVZWNVXHRD-UHFFFAOYSA-N 0.000 claims description 2
- IPQMSMALOWIGBZ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(3-chlorophenyl)acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C=C(Cl)C=CC=2)=CC=C1OCCN IPQMSMALOWIGBZ-UHFFFAOYSA-N 0.000 claims description 2
- LYEPQZABESXTMZ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(3-fluoro-4-methoxyphenyl)acetamide Chemical compound C1=C(F)C(OC)=CC=C1CC(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 LYEPQZABESXTMZ-UHFFFAOYSA-N 0.000 claims description 2
- AOPJUROQWVXVGC-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(3-fluorophenyl)acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C=C(F)C=CC=2)=CC=C1OCCN AOPJUROQWVXVGC-UHFFFAOYSA-N 0.000 claims description 2
- CTODKIMOGBSIMV-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(3-methoxyphenyl)acetamide Chemical compound COC1=CC=CC(CC(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1 CTODKIMOGBSIMV-UHFFFAOYSA-N 0.000 claims description 2
- UZTVUNXYEBAWQD-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(3-methylphenyl)acetamide Chemical compound CC1=CC=CC(CC(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1 UZTVUNXYEBAWQD-UHFFFAOYSA-N 0.000 claims description 2
- QYCNUOPDNOSNBG-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(4-chlorophenyl)-2-oxoacetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C(=O)C=2C=CC(Cl)=CC=2)=CC=C1OCCN QYCNUOPDNOSNBG-UHFFFAOYSA-N 0.000 claims description 2
- CDGAKPBJHAUKSP-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(4-chlorophenyl)acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C=CC(Cl)=CC=2)=CC=C1OCCN CDGAKPBJHAUKSP-UHFFFAOYSA-N 0.000 claims description 2
- FFRHZNYHCQFSHO-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(4-fluorophenyl)-2-oxoacetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C(=O)C=2C=CC(F)=CC=2)=CC=C1OCCN FFRHZNYHCQFSHO-UHFFFAOYSA-N 0.000 claims description 2
- OEMURFOQDLXKIC-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(4-fluorophenyl)acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C=CC(F)=CC=2)=CC=C1OCCN OEMURFOQDLXKIC-UHFFFAOYSA-N 0.000 claims description 2
- GIKKRJVJYOPAGV-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(4-methoxyphenyl)-2-oxoacetamide Chemical compound C1=CC(OC)=CC=C1C(=O)C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 GIKKRJVJYOPAGV-UHFFFAOYSA-N 0.000 claims description 2
- RAUWZBHWQANEQA-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(4-methoxyphenyl)acetamide Chemical compound C1=CC(OC)=CC=C1CC(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 RAUWZBHWQANEQA-UHFFFAOYSA-N 0.000 claims description 2
- POKINRZLSUSUNR-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(4-methylphenyl)-2-oxoacetamide Chemical compound C1=CC(C)=CC=C1C(=O)C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 POKINRZLSUSUNR-UHFFFAOYSA-N 0.000 claims description 2
- LYMOUVHKHSRAAJ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(dimethylamino)benzamide Chemical compound CN(C)C1=CC=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 LYMOUVHKHSRAAJ-UHFFFAOYSA-N 0.000 claims description 2
- WTFKHLVIRJRKRJ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-[2-(trifluoromethyl)phenyl]acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C(=CC=CC=2)C(F)(F)F)=CC=C1OCCN WTFKHLVIRJRKRJ-UHFFFAOYSA-N 0.000 claims description 2
- SWEJXWALSGCIEQ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-[3-(trifluoromethyl)phenyl]acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C=C(C=CC=2)C(F)(F)F)=CC=C1OCCN SWEJXWALSGCIEQ-UHFFFAOYSA-N 0.000 claims description 2
- LQTVLJMXHQFBSV-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-[4-(trifluoromethyl)phenyl]acetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C=CC(=CC=2)C(F)(F)F)=CC=C1OCCN LQTVLJMXHQFBSV-UHFFFAOYSA-N 0.000 claims description 2
- GLFZPLCNVMNKAM-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-bromo-5-methoxybenzamide Chemical compound COC1=CC=C(Br)C(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1 GLFZPLCNVMNKAM-UHFFFAOYSA-N 0.000 claims description 2
- KDCZNTLORXSVCT-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-chloro-6-fluorobenzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C(=CC=CC=2F)Cl)=CC=C1OCCN KDCZNTLORXSVCT-UHFFFAOYSA-N 0.000 claims description 2
- UEDLBHFGEWBIQQ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-cyanobenzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C(=CC=CC=2)C#N)=CC=C1OCCN UEDLBHFGEWBIQQ-UHFFFAOYSA-N 0.000 claims description 2
- LWNVYSQLEVNOBL-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-ethyl-5-methylpyrazole-3-carboxamide Chemical compound CCN1N=C(C)C=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 LWNVYSQLEVNOBL-UHFFFAOYSA-N 0.000 claims description 2
- ISVBSLAALYPLOK-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-fluoro-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1F ISVBSLAALYPLOK-UHFFFAOYSA-N 0.000 claims description 2
- KBPSNSUZRRVFLY-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-fluoro-4-(trifluoromethyl)benzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C(=CC(=CC=2)C(F)(F)F)F)=CC=C1OCCN KBPSNSUZRRVFLY-UHFFFAOYSA-N 0.000 claims description 2
- PUAAVNNVWGTDQA-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-fluoro-4-methoxybenzamide Chemical compound FC1=CC(OC)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 PUAAVNNVWGTDQA-UHFFFAOYSA-N 0.000 claims description 2
- FMQFTHQAUDROTF-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-fluoro-5-(trifluoromethyl)benzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C(=CC=C(C=2)C(F)(F)F)F)=CC=C1OCCN FMQFTHQAUDROTF-UHFFFAOYSA-N 0.000 claims description 2
- PZVKEUTZNOAORP-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-fluoro-5-methoxybenzamide Chemical compound COC1=CC=C(F)C(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1 PZVKEUTZNOAORP-UHFFFAOYSA-N 0.000 claims description 2
- XXUIKMLHHHSYHL-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-methylfuran-3-carboxamide Chemical compound O1C=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1C XXUIKMLHHHSYHL-UHFFFAOYSA-N 0.000 claims description 2
- CJUAQMIVHIXLNT-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-methylpyridine-3-carboxamide Chemical compound CC1=NC=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 CJUAQMIVHIXLNT-UHFFFAOYSA-N 0.000 claims description 2
- DLJGJHHTYWCFGY-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-morpholin-4-ylbenzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C(=CC=CC=2)N2CCOCC2)=CC=C1OCCN DLJGJHHTYWCFGY-UHFFFAOYSA-N 0.000 claims description 2
- WZVRKWTZXNDSSU-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-phenylacetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC=2C=CC=CC=2)=CC=C1OCCN WZVRKWTZXNDSSU-UHFFFAOYSA-N 0.000 claims description 2
- NQPWUTPFBNJKHM-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-thiophen-3-ylacetamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CC2=CSC=C2)=CC=C1OCCN NQPWUTPFBNJKHM-UHFFFAOYSA-N 0.000 claims description 2
- ZWMLVUKMIYLXLM-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3,4,5-trimethoxybenzamide Chemical compound COC1=C(OC)C(OC)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1 ZWMLVUKMIYLXLM-UHFFFAOYSA-N 0.000 claims description 2
- BWKDXPRVIZEKJR-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3,4-dihydro-1h-isoquinoline-2-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)N2CC3=CC=CC=C3CC2)=CC=C1OCCN BWKDXPRVIZEKJR-UHFFFAOYSA-N 0.000 claims description 2
- RZLKFZSUXDJWOZ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3,4-dihydro-2h-quinoline-1-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)N2C3=CC=CC=C3CCC2)=CC=C1OCCN RZLKFZSUXDJWOZ-UHFFFAOYSA-N 0.000 claims description 2
- XFEGSSWTCFMAGB-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3,5-dichloropyridine-4-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C(=CN=CC=2Cl)Cl)=CC=C1OCCN XFEGSSWTCFMAGB-UHFFFAOYSA-N 0.000 claims description 2
- KLVXUOCHVJKIFE-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3,5-difluorobenzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=C(F)C=C(F)C=2)=CC=C1OCCN KLVXUOCHVJKIFE-UHFFFAOYSA-N 0.000 claims description 2
- HKBBAFHKWVYIMD-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3,5-dimethyl-1,2-oxazole-4-carboxamide Chemical compound CC1=NOC(C)=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 HKBBAFHKWVYIMD-UHFFFAOYSA-N 0.000 claims description 2
- AMUKBRHILKUCMG-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3,5-dimethyl-1h-pyrrole-2-carboxamide Chemical compound N1C(C)=CC(C)=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 AMUKBRHILKUCMG-UHFFFAOYSA-N 0.000 claims description 2
- XWDMQZWNWWMSCM-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-(1h-indol-3-yl)propanamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CCC=2C3=CC=CC=C3NC=2)=CC=C1OCCN XWDMQZWNWWMSCM-UHFFFAOYSA-N 0.000 claims description 2
- ZZQOELOKMOKSAV-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-(2-methoxyphenyl)propanamide Chemical compound COC1=CC=CC=C1CCC(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 ZZQOELOKMOKSAV-UHFFFAOYSA-N 0.000 claims description 2
- SRDJVTGFSUHNJZ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-bromo-4-methoxybenzamide Chemical compound C1=C(Br)C(OC)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 SRDJVTGFSUHNJZ-UHFFFAOYSA-N 0.000 claims description 2
- IALQVXHBZFWYMY-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-chloro-1-benzothiophene-2-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C2=C(C3=CC=CC=C3S2)Cl)=CC=C1OCCN IALQVXHBZFWYMY-UHFFFAOYSA-N 0.000 claims description 2
- QSLDKTCJPVJAOO-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-chloro-4-fluorobenzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=C(Cl)C(F)=CC=2)=CC=C1OCCN QSLDKTCJPVJAOO-UHFFFAOYSA-N 0.000 claims description 2
- JKTCKAXIBYUPAO-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-chloro-4-methoxybenzamide Chemical compound C1=C(Cl)C(OC)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 JKTCKAXIBYUPAO-UHFFFAOYSA-N 0.000 claims description 2
- DCWLICKOHFXBOD-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-chloro-6-fluoro-1-benzothiophene-2-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C2=C(C3=CC=C(F)C=C3S2)Cl)=CC=C1OCCN DCWLICKOHFXBOD-UHFFFAOYSA-N 0.000 claims description 2
- DLSDOCGINQLZQJ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-chlorothiophene-2-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C2=C(C=CS2)Cl)=CC=C1OCCN DLSDOCGINQLZQJ-UHFFFAOYSA-N 0.000 claims description 2
- GOMBGZWOAHAALJ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-cyanobenzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=C(C=CC=2)C#N)=CC=C1OCCN GOMBGZWOAHAALJ-UHFFFAOYSA-N 0.000 claims description 2
- PRSMJUSUHAYXPN-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-cyclohexylpropanamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)CCC2CCCCC2)=CC=C1OCCN PRSMJUSUHAYXPN-UHFFFAOYSA-N 0.000 claims description 2
- OTEUYARTHCGQEO-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-cyclopentyloxy-4-methoxybenzamide Chemical compound COC1=CC=C(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)C=C1OC1CCCC1 OTEUYARTHCGQEO-UHFFFAOYSA-N 0.000 claims description 2
- ONEJUVIPXJOSFT-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-ethoxythiophene-2-carboxamide Chemical compound C1=CSC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1OCC ONEJUVIPXJOSFT-UHFFFAOYSA-N 0.000 claims description 2
- MXOJKDKRGVWCRV-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-fluoro-4-(trifluoromethyl)benzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=C(F)C(=CC=2)C(F)(F)F)=CC=C1OCCN MXOJKDKRGVWCRV-UHFFFAOYSA-N 0.000 claims description 2
- YKWBEDGAFKEFQF-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-fluoro-4-methoxybenzamide Chemical compound C1=C(F)C(OC)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 YKWBEDGAFKEFQF-UHFFFAOYSA-N 0.000 claims description 2
- HGAIUKJDPXAIEG-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-fluoro-5-(trifluoromethyl)benzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=C(C=C(F)C=2)C(F)(F)F)=CC=C1OCCN HGAIUKJDPXAIEG-UHFFFAOYSA-N 0.000 claims description 2
- BVUOIGYZVITIGA-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-fluorobenzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=C(F)C=CC=2)=CC=C1OCCN BVUOIGYZVITIGA-UHFFFAOYSA-N 0.000 claims description 2
- KOXORADNRUNSHY-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-methoxy-2-methylbenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1C KOXORADNRUNSHY-UHFFFAOYSA-N 0.000 claims description 2
- IKKJKPILQDHCDI-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1 IKKJKPILQDHCDI-UHFFFAOYSA-N 0.000 claims description 2
- YAWOVPOJLQTFKY-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-methoxycyclohexane-1-carboxamide Chemical compound C1C(OC)CCCC1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 YAWOVPOJLQTFKY-UHFFFAOYSA-N 0.000 claims description 2
- LLFZAAOSPXWHII-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-methyl-1-benzofuran-2-carboxamide Chemical compound O1C2=CC=CC=C2C(C)=C1C(=O)NC(C=1)=CC=C(OCCN)C=1C1=CC=NN1C LLFZAAOSPXWHII-UHFFFAOYSA-N 0.000 claims description 2
- WIDNFBOWJXVDJR-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-methylimidazole-4-carboxamide Chemical compound CN1C=NC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 WIDNFBOWJXVDJR-UHFFFAOYSA-N 0.000 claims description 2
- JUMAPQTYFJNEJT-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-methylthiophene-2-carboxamide Chemical compound C1=CSC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1C JUMAPQTYFJNEJT-UHFFFAOYSA-N 0.000 claims description 2
- LPELZYKYQPMQSK-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-phenyl-1,2-oxazole-5-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2ON=C(C=2)C=2C=CC=CC=2)=CC=C1OCCN LPELZYKYQPMQSK-UHFFFAOYSA-N 0.000 claims description 2
- IKQCMOKXIOKSKA-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4,5-dichloro-1,2-thiazole-3-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C(=C(Cl)SN=2)Cl)=CC=C1OCCN IKQCMOKXIOKSKA-UHFFFAOYSA-N 0.000 claims description 2
- MBOISBBJQGONJU-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4,5-dimethylfuran-2-carboxamide Chemical compound O1C(C)=C(C)C=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 MBOISBBJQGONJU-UHFFFAOYSA-N 0.000 claims description 2
- INNKTCAPUYUKRG-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-(trifluoromethoxy)benzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=CC(OC(F)(F)F)=CC=2)=CC=C1OCCN INNKTCAPUYUKRG-UHFFFAOYSA-N 0.000 claims description 2
- GFNYJEDBELHWOE-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-bromo-1-methylpyrazole-3-carboxamide Chemical compound CN1C=C(Br)C(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=N1 GFNYJEDBELHWOE-UHFFFAOYSA-N 0.000 claims description 2
- VADDJIRPPRYCRR-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-bromo-3-methylbenzamide Chemical compound C1=C(Br)C(C)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1 VADDJIRPPRYCRR-UHFFFAOYSA-N 0.000 claims description 2
- OXWPGFOFSWWUOI-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-bromothiophene-2-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2SC=C(Br)C=2)=CC=C1OCCN OXWPGFOFSWWUOI-UHFFFAOYSA-N 0.000 claims description 2
- JFFIPYSNDBGMLG-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-chloro-1-ethylpyrazole-3-carboxamide Chemical compound CCN1C=C(Cl)C(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=N1 JFFIPYSNDBGMLG-UHFFFAOYSA-N 0.000 claims description 2
- PEYIXMKHWFZPMD-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-chloro-1-methylpyrazole-3-carboxamide Chemical compound CN1C=C(Cl)C(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=N1 PEYIXMKHWFZPMD-UHFFFAOYSA-N 0.000 claims description 2
- RVUBMQAZTPJPQN-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-chloro-2,3-dihydroindole-1-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)N2C3=C(C(=CC=C3)Cl)CC2)=CC=C1OCCN RVUBMQAZTPJPQN-UHFFFAOYSA-N 0.000 claims description 2
- HEKLMSNCRKWTQL-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-chloropyridine-3-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C(=CC=NC=2)Cl)=CC=C1OCCN HEKLMSNCRKWTQL-UHFFFAOYSA-N 0.000 claims description 2
- IARKZBPHYRXAQG-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-fluoro-3-(trifluoromethyl)benzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=C(C(F)=CC=2)C(F)(F)F)=CC=C1OCCN IARKZBPHYRXAQG-UHFFFAOYSA-N 0.000 claims description 2
- ODPXKDOXPWZICM-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-fluoro-3-methoxybenzamide Chemical compound C1=C(F)C(OC)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1 ODPXKDOXPWZICM-UHFFFAOYSA-N 0.000 claims description 2
- IKDYLGYTPCTUIC-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-fluoro-5-methyl-1h-pyrazole-3-carboxamide Chemical compound FC1=C(C)NN=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 IKDYLGYTPCTUIC-UHFFFAOYSA-N 0.000 claims description 2
- LTSOAEGHBWNQSN-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-fluorobenzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=CC(F)=CC=2)=CC=C1OCCN LTSOAEGHBWNQSN-UHFFFAOYSA-N 0.000 claims description 2
- HQGNSSLKPHDITC-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-methoxy-2-methylbenzamide Chemical compound CC1=CC(OC)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 HQGNSSLKPHDITC-UHFFFAOYSA-N 0.000 claims description 2
- ASHFEBBHJFAAES-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-methoxy-3,5-dimethylbenzamide Chemical compound C1=C(C)C(OC)=C(C)C=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 ASHFEBBHJFAAES-UHFFFAOYSA-N 0.000 claims description 2
- RELBPLWWMXLMQE-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-methoxy-3-(trifluoromethyl)benzamide Chemical compound C1=C(C(F)(F)F)C(OC)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 RELBPLWWMXLMQE-UHFFFAOYSA-N 0.000 claims description 2
- UELSBQQIJQKFNB-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-methoxycyclohexane-1-carboxamide Chemical compound C1CC(OC)CCC1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 UELSBQQIJQKFNB-UHFFFAOYSA-N 0.000 claims description 2
- KVTSRHMOULYGCA-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-methoxythiophene-3-carboxamide Chemical compound COC1=CSC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 KVTSRHMOULYGCA-UHFFFAOYSA-N 0.000 claims description 2
- KMAPJTALEFWVFF-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-methyl-1,3-oxazole-5-carboxamide Chemical compound N1=COC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1C KMAPJTALEFWVFF-UHFFFAOYSA-N 0.000 claims description 2
- KJEMXEKACUYTDC-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-methyl-2,3-dihydro-1,4-benzoxazine-7-carboxamide Chemical compound C=1C=C2N(C)CCOC2=CC=1C(=O)NC(C=1)=CC=C(OCCN)C=1C1=CC=NN1C KJEMXEKACUYTDC-UHFFFAOYSA-N 0.000 claims description 2
- CDUJZJUURHSPMV-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-methylbenzamide Chemical compound C1=CC(C)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 CDUJZJUURHSPMV-UHFFFAOYSA-N 0.000 claims description 2
- DWBGYPRVBFUNSU-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-methylthiadiazole-5-carboxamide Chemical compound N1=NSC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1C DWBGYPRVBFUNSU-UHFFFAOYSA-N 0.000 claims description 2
- ZAJCPSAJXHNCOJ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-methylthiophene-2-carboxamide Chemical compound CC1=CSC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1 ZAJCPSAJXHNCOJ-UHFFFAOYSA-N 0.000 claims description 2
- QGDNZCSMSUFCMT-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-thiophen-2-ylbenzamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=CC(=CC=2)C=2SC=CC=2)=CC=C1OCCN QGDNZCSMSUFCMT-UHFFFAOYSA-N 0.000 claims description 2
- WQJMSOVUUHZVAN-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-5-bromofuran-2-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2OC(Br)=CC=2)=CC=C1OCCN WQJMSOVUUHZVAN-UHFFFAOYSA-N 0.000 claims description 2
- GPDZFZLZSDYBSA-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-5-butyl-4-fluoro-1h-pyrazole-3-carboxamide Chemical compound FC1=C(CCCC)NN=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 GPDZFZLZSDYBSA-UHFFFAOYSA-N 0.000 claims description 2
- BKWVJOSINCDQSL-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-5-cyclopropyl-4-fluoro-1h-pyrazole-3-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C(=C(C3CC3)NN=2)F)=CC=C1OCCN BKWVJOSINCDQSL-UHFFFAOYSA-N 0.000 claims description 2
- LPSJMYXOKGBONR-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-5-ethyl-4-fluoro-1h-pyrazole-3-carboxamide Chemical compound FC1=C(CC)NN=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 LPSJMYXOKGBONR-UHFFFAOYSA-N 0.000 claims description 2
- XNVJPSCCGLKPNL-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide Chemical compound O1C(C)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=N1 XNVJPSCCGLKPNL-UHFFFAOYSA-N 0.000 claims description 2
- UUNWOYXFQYHHCR-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-5-methyl-1,2-oxazole-4-carboxamide Chemical compound O1N=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1C UUNWOYXFQYHHCR-UHFFFAOYSA-N 0.000 claims description 2
- DFNRTAXIYHSEFI-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-5-methyl-2-(trifluoromethyl)furan-3-carboxamide Chemical compound O1C(C)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1C(F)(F)F DFNRTAXIYHSEFI-UHFFFAOYSA-N 0.000 claims description 2
- IEFDCFHRUZBJEZ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-5-methylthiophene-2-carboxamide Chemical compound S1C(C)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 IEFDCFHRUZBJEZ-UHFFFAOYSA-N 0.000 claims description 2
- OIOTYNPKNDYLGC-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-5-phenyl-1,2-oxazole-3-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C2=NOC(=C2)C=2C=CC=CC=2)=CC=C1OCCN OIOTYNPKNDYLGC-UHFFFAOYSA-N 0.000 claims description 2
- DYCGRRSFPYGJAJ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-5-propan-2-yl-1,2-oxazole-3-carboxamide Chemical compound O1C(C(C)C)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=N1 DYCGRRSFPYGJAJ-UHFFFAOYSA-N 0.000 claims description 2
- DSGKHKZWHOCYQL-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-5-propan-2-yl-1h-pyrazole-3-carboxamide Chemical compound N1N=C(C(C)C)C=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 DSGKHKZWHOCYQL-UHFFFAOYSA-N 0.000 claims description 2
- YYKVLLDBDHOKTM-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-5-tert-butyl-2-methylfuran-3-carboxamide Chemical compound O1C(C(C)(C)C)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1C YYKVLLDBDHOKTM-UHFFFAOYSA-N 0.000 claims description 2
- KDWPGLAHHRQQDZ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-5-tert-butyl-2-methylpyrazole-3-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2N(N=C(C=2)C(C)(C)C)C)=CC=C1OCCN KDWPGLAHHRQQDZ-UHFFFAOYSA-N 0.000 claims description 2
- IJZXWHUKVBGCDF-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-6-(trifluoromethyl)pyridine-3-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=NC(=CC=2)C(F)(F)F)=CC=C1OCCN IJZXWHUKVBGCDF-UHFFFAOYSA-N 0.000 claims description 2
- WPCVCWDQZUACHT-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-6-cyanopyridine-3-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=NC(=CC=2)C#N)=CC=C1OCCN WPCVCWDQZUACHT-UHFFFAOYSA-N 0.000 claims description 2
- KRIQEIQURVVHNI-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-6-fluoro-2,3-dihydroindole-1-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)N2C3=CC(F)=CC=C3CC2)=CC=C1OCCN KRIQEIQURVVHNI-UHFFFAOYSA-N 0.000 claims description 2
- AYNAXJWYJUQABW-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-6-methylpyridine-2-carboxamide Chemical compound CC1=CC=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=N1 AYNAXJWYJUQABW-UHFFFAOYSA-N 0.000 claims description 2
- OPVFBYWNORZMKD-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-6-methylpyridine-3-carboxamide Chemical compound C1=NC(C)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 OPVFBYWNORZMKD-UHFFFAOYSA-N 0.000 claims description 2
- VPFGYUKKZKWSME-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-6-morpholin-4-ylpyridine-3-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=NC(=CC=2)N2CCOCC2)=CC=C1OCCN VPFGYUKKZKWSME-UHFFFAOYSA-N 0.000 claims description 2
- KXOAQJNBMVONOH-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-6-oxo-1h-pyridine-3-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C2=CNC(=O)C=C2)=CC=C1OCCN KXOAQJNBMVONOH-UHFFFAOYSA-N 0.000 claims description 2
- PGSMVRULIOEWNG-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-6-phenoxypyridine-3-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=NC(OC=3C=CC=CC=3)=CC=2)=CC=C1OCCN PGSMVRULIOEWNG-UHFFFAOYSA-N 0.000 claims description 2
- ABJKGCLZHZVDRA-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]cyclopentanecarboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C2CCCC2)=CC=C1OCCN ABJKGCLZHZVDRA-UHFFFAOYSA-N 0.000 claims description 2
- OGAPBICHARYDMG-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]furan-2-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2OC=CC=2)=CC=C1OCCN OGAPBICHARYDMG-UHFFFAOYSA-N 0.000 claims description 2
- PQVMVYVJZDIXRF-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]naphthalene-2-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=C3C=CC=CC3=CC=2)=CC=C1OCCN PQVMVYVJZDIXRF-UHFFFAOYSA-N 0.000 claims description 2
- PNURZEZTENPKGV-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]propanamide Chemical compound CCC(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 PNURZEZTENPKGV-UHFFFAOYSA-N 0.000 claims description 2
- AHERFTPQJAITFQ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]pyridine-4-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2C=CN=CC=2)=CC=C1OCCN AHERFTPQJAITFQ-UHFFFAOYSA-N 0.000 claims description 2
- PIYWXQAUQAIUKG-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]quinoline-2-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C=2N=C3C=CC=CC3=CC=2)=CC=C1OCCN PIYWXQAUQAIUKG-UHFFFAOYSA-N 0.000 claims description 2
- LGMZYUSXICYXMV-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]thiophene-3-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C2=CSC=C2)=CC=C1OCCN LGMZYUSXICYXMV-UHFFFAOYSA-N 0.000 claims description 2
- AZFWLWQGWCTGCD-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-2,5-dihydropyrrole-1-carboxamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)N2CC=CC2)=CC=C1OCCN AZFWLWQGWCTGCD-UHFFFAOYSA-N 0.000 claims description 2
- HCWJDHCLLRQESM-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-3,4-dihydro-2h-quinoline-1-carboxamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)N2C3=CC=CC=C3CCC2)=CC=C1OCCN HCWJDHCLLRQESM-UHFFFAOYSA-N 0.000 claims description 2
- GARONBAGOPNOJT-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-4-(3,5-dichloropyridin-4-yl)piperazine-1-carboxamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)N2CCN(CC2)C=2C(=CN=CC=2Cl)Cl)=CC=C1OCCN GARONBAGOPNOJT-UHFFFAOYSA-N 0.000 claims description 2
- KXDMWQVPOVXASZ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-4-[5-(trifluoromethyl)pyridin-2-yl]piperazine-1-carboxamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)N2CCN(CC2)C=2N=CC(=CC=2)C(F)(F)F)=CC=C1OCCN KXDMWQVPOVXASZ-UHFFFAOYSA-N 0.000 claims description 2
- ILMWVIWCYNLUNA-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-4-methylpiperazine-1-carboxamide Chemical compound C1CN(C)CCN1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Br)C)=C1 ILMWVIWCYNLUNA-UHFFFAOYSA-N 0.000 claims description 2
- FQQJQEGMOXKFKX-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-4-pyridin-2-ylpiperazine-1-carboxamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)N2CCN(CC2)C=2N=CC=CC=2)=CC=C1OCCN FQQJQEGMOXKFKX-UHFFFAOYSA-N 0.000 claims description 2
- BPFNPMWQUDBKNI-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-5,6-dihydro-4h-pyrimidine-1-carboxamide Chemical compound CN1N=CC(Br)=C1C1=CC(NC(=O)N2C=NCCC2)=CC=C1OCCN BPFNPMWQUDBKNI-UHFFFAOYSA-N 0.000 claims description 2
- NHUJFLSSWXKQTH-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-6,7-dimethoxy-3,4-dihydro-1h-isoquinoline-2-carboxamide Chemical compound C1C=2C=C(OC)C(OC)=CC=2CCN1C(=O)NC(C=1)=CC=C(OCCN)C=1C1=C(Br)C=NN1C NHUJFLSSWXKQTH-UHFFFAOYSA-N 0.000 claims description 2
- BEEZLSADSKJBNJ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-1,3-benzodioxole-5-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=C3OCOC3=CC=2)=CC=C1OCCN BEEZLSADSKJBNJ-UHFFFAOYSA-N 0.000 claims description 2
- FYQPLSDNAAVJNY-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-1,3-thiazole-4-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2N=CSC=2)=CC=C1OCCN FYQPLSDNAAVJNY-UHFFFAOYSA-N 0.000 claims description 2
- DQAJPBRWFLDLFV-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-1,5-dimethylpyrazole-3-carboxamide Chemical compound CN1C(C)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=N1 DQAJPBRWFLDLFV-UHFFFAOYSA-N 0.000 claims description 2
- BXMCNOLSDNOZRZ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-1-(4-chlorophenyl)-5-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C2=C(N(N=C2)C=2C=CC(Cl)=CC=2)C(F)(F)F)=CC=C1OCCN BXMCNOLSDNOZRZ-UHFFFAOYSA-N 0.000 claims description 2
- ZVJYCTLKXWIFDK-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound FC(F)(F)C1=NN(C)C=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 ZVJYCTLKXWIFDK-UHFFFAOYSA-N 0.000 claims description 2
- CYRDQVSPFNGKMD-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-1-methylimidazole-4-carboxamide Chemical compound CN1C=NC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1 CYRDQVSPFNGKMD-UHFFFAOYSA-N 0.000 claims description 2
- WVQLJJOSSKJQSJ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-1-methylpyrrole-2-carboxamide Chemical compound CN1C=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 WVQLJJOSSKJQSJ-UHFFFAOYSA-N 0.000 claims description 2
- LXOJASIGNROYOY-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-1-phenyl-5-(trifluoromethyl)pyrazole-3-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C2=NN(C(=C2)C(F)(F)F)C=2C=CC=CC=2)=CC=C1OCCN LXOJASIGNROYOY-UHFFFAOYSA-N 0.000 claims description 2
- PSKMJAFLIFYCKS-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-1h-indole-2-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2NC3=CC=CC=C3C=2)=CC=C1OCCN PSKMJAFLIFYCKS-UHFFFAOYSA-N 0.000 claims description 2
- YDRXIQLXODECTL-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2,1-benzoxazole-3-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C2=C3C=CC=CC3=NO2)=CC=C1OCCN YDRXIQLXODECTL-UHFFFAOYSA-N 0.000 claims description 2
- DGRZHTCOECBFJI-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2,2-difluoro-1,3-benzodioxole-4-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=3OC(F)(F)OC=3C=CC=2)=CC=C1OCCN DGRZHTCOECBFJI-UHFFFAOYSA-N 0.000 claims description 2
- IRPRVFMPRGIUTQ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2,2-difluoro-1,3-benzodioxole-5-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=C3OC(F)(F)OC3=CC=2)=CC=C1OCCN IRPRVFMPRGIUTQ-UHFFFAOYSA-N 0.000 claims description 2
- SPBSHGXVVCXTMZ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2,2-difluorocyclopropane-1-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C2C(C2)(F)F)=CC=C1OCCN SPBSHGXVVCXTMZ-UHFFFAOYSA-N 0.000 claims description 2
- AOVKCHPUACURPM-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2,2-dimethylpropanamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C(C)(C)C)=CC=C1OCCN AOVKCHPUACURPM-UHFFFAOYSA-N 0.000 claims description 2
- IABDOYCZKJFQQI-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2,4,5-trifluoro-3-methoxybenzamide Chemical compound COC1=C(F)C(F)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1F IABDOYCZKJFQQI-UHFFFAOYSA-N 0.000 claims description 2
- KRCLNYQOMMMDOA-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2,4-dimethyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C)=NC(C)=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 KRCLNYQOMMMDOA-UHFFFAOYSA-N 0.000 claims description 2
- JKOFSJPZXVBSBW-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2,5-dichlorothiophene-3-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C2=C(SC(Cl)=C2)Cl)=CC=C1OCCN JKOFSJPZXVBSBW-UHFFFAOYSA-N 0.000 claims description 2
- DPFKPSIMNOIAIJ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2,6-difluoro-4-methoxybenzamide Chemical compound FC1=CC(OC)=CC(F)=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 DPFKPSIMNOIAIJ-UHFFFAOYSA-N 0.000 claims description 2
- UTHKBURRNYKKIY-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2-bromo-4-methyl-1,3-thiazole-5-carboxamide Chemical compound N1=C(Br)SC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1C UTHKBURRNYKKIY-UHFFFAOYSA-N 0.000 claims description 2
- IDPRQNDSYNSEIO-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2-bromo-5-methoxybenzamide Chemical compound COC1=CC=C(Br)C(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1 IDPRQNDSYNSEIO-UHFFFAOYSA-N 0.000 claims description 2
- FODSHTNSNBNWNI-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2-fluoro-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1F FODSHTNSNBNWNI-UHFFFAOYSA-N 0.000 claims description 2
- SOMCRDKJLMQTRJ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2-fluoro-4-methoxybenzamide Chemical compound FC1=CC(OC)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 SOMCRDKJLMQTRJ-UHFFFAOYSA-N 0.000 claims description 2
- HYUGERLAWKTRQF-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2-methylsulfanylpyridine-3-carboxamide Chemical compound CSC1=NC=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 HYUGERLAWKTRQF-UHFFFAOYSA-N 0.000 claims description 2
- FKIHNVVSYLBURO-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2-phenoxypyridine-3-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C(=NC=CC=2)OC=2C=CC=CC=2)=CC=C1OCCN FKIHNVVSYLBURO-UHFFFAOYSA-N 0.000 claims description 2
- FENQPGJDRUXXOS-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2h-benzotriazole-5-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=C3N=NNC3=CC=2)=CC=C1OCCN FENQPGJDRUXXOS-UHFFFAOYSA-N 0.000 claims description 2
- FATCUFKONYNEME-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3,4-difluorobenzamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=C(F)C(F)=CC=2)=CC=C1OCCN FATCUFKONYNEME-UHFFFAOYSA-N 0.000 claims description 2
- HWVFDLMXHOJREC-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3,5-difluorobenzamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=C(F)C=C(F)C=2)=CC=C1OCCN HWVFDLMXHOJREC-UHFFFAOYSA-N 0.000 claims description 2
- DAPDDJUHYAQAFH-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3,5-dimethyl-1,2-oxazole-4-carboxamide Chemical compound CC1=NOC(C)=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 DAPDDJUHYAQAFH-UHFFFAOYSA-N 0.000 claims description 2
- WLJAKNNRXPGWIB-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-(1,1,2,2-tetrafluoroethoxy)benzamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=C(OC(F)(F)C(F)F)C=CC=2)=CC=C1OCCN WLJAKNNRXPGWIB-UHFFFAOYSA-N 0.000 claims description 2
- UJXFHMOOGNPDRT-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-(dimethylamino)benzamide Chemical compound CN(C)C1=CC=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1 UJXFHMOOGNPDRT-UHFFFAOYSA-N 0.000 claims description 2
- ZISZXYPNLAYYFP-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-bromo-4-methoxybenzamide Chemical compound C1=C(Br)C(OC)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 ZISZXYPNLAYYFP-UHFFFAOYSA-N 0.000 claims description 2
- VYYUATAVVVHGEP-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-chloro-6-fluoro-1-benzothiophene-2-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C2=C(C3=CC=C(F)C=C3S2)Cl)=CC=C1OCCN VYYUATAVVVHGEP-UHFFFAOYSA-N 0.000 claims description 2
- ZEZCZZPNILZYNV-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-chlorothiophene-2-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C2=C(C=CS2)Cl)=CC=C1OCCN ZEZCZZPNILZYNV-UHFFFAOYSA-N 0.000 claims description 2
- YHHUTUILTOJVAQ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-cyclopentyloxy-4-methoxybenzamide Chemical compound COC1=CC=C(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)C=C1OC1CCCC1 YHHUTUILTOJVAQ-UHFFFAOYSA-N 0.000 claims description 2
- AIQIESBFYGRVQK-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-ethoxybenzamide Chemical compound CCOC1=CC=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1 AIQIESBFYGRVQK-UHFFFAOYSA-N 0.000 claims description 2
- YHBNMWRAROJHSL-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-ethoxythiophene-2-carboxamide Chemical compound C1=CSC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1OCC YHBNMWRAROJHSL-UHFFFAOYSA-N 0.000 claims description 2
- SRUQYGVJVHMNGC-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-fluoro-4-methoxybenzamide Chemical compound C1=C(F)C(OC)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 SRUQYGVJVHMNGC-UHFFFAOYSA-N 0.000 claims description 2
- JGWSUTZUUABIHK-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-fluoro-4-methylbenzamide Chemical compound C1=C(F)C(C)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 JGWSUTZUUABIHK-UHFFFAOYSA-N 0.000 claims description 2
- KQBLLNNAOYJUBF-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-fluoropyridine-4-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C(=CN=CC=2)F)=CC=C1OCCN KQBLLNNAOYJUBF-UHFFFAOYSA-N 0.000 claims description 2
- KTALXEUFBCWMRU-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-methoxy-2-methylbenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1C KTALXEUFBCWMRU-UHFFFAOYSA-N 0.000 claims description 2
- NNUIHSBHORCAAE-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-methoxy-4-methylbenzamide Chemical compound C1=C(C)C(OC)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1 NNUIHSBHORCAAE-UHFFFAOYSA-N 0.000 claims description 2
- GZXUHCBIQFDYHV-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-methyl-1,2-oxazole-4-carboxamide Chemical compound CC1=NOC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 GZXUHCBIQFDYHV-UHFFFAOYSA-N 0.000 claims description 2
- JAUUOZHXZLYRHM-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-methyl-1-benzofuran-2-carboxamide Chemical compound O1C2=CC=CC=C2C(C)=C1C(=O)NC(C=1)=CC=C(OCCN)C=1C1=C(Cl)C=NN1C JAUUOZHXZLYRHM-UHFFFAOYSA-N 0.000 claims description 2
- SEMMOYPWNUEVGB-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-methylthiophene-2-carboxamide Chemical compound C1=CSC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1C SEMMOYPWNUEVGB-UHFFFAOYSA-N 0.000 claims description 2
- JVDGAXQJJQAPKO-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4,4-difluorocyclohexane-1-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C2CCC(F)(F)CC2)=CC=C1OCCN JVDGAXQJJQAPKO-UHFFFAOYSA-N 0.000 claims description 2
- ZYQPUJZOAIUQEW-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4,5-dimethylfuran-2-carboxamide Chemical compound O1C(C)=C(C)C=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 ZYQPUJZOAIUQEW-UHFFFAOYSA-N 0.000 claims description 2
- BFAWNVZZIYXFCC-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-(dimethylamino)benzamide Chemical compound C1=CC(N(C)C)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 BFAWNVZZIYXFCC-UHFFFAOYSA-N 0.000 claims description 2
- IYXOGPUSAMQKGR-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-(trifluoromethyl)cyclohexane-1-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C2CCC(CC2)C(F)(F)F)=CC=C1OCCN IYXOGPUSAMQKGR-UHFFFAOYSA-N 0.000 claims description 2
- TUBOXUHIUZDBKB-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]benzamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=CC(CN3CCS(=O)(=O)CC3)=CC=2)=CC=C1OCCN TUBOXUHIUZDBKB-UHFFFAOYSA-N 0.000 claims description 2
- WOTDQLLOCUEMGR-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-bromobenzamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=CC(Br)=CC=2)=CC=C1OCCN WOTDQLLOCUEMGR-UHFFFAOYSA-N 0.000 claims description 2
- JQENFBOQQWPMCQ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-bromothiophene-2-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2SC=C(Br)C=2)=CC=C1OCCN JQENFBOQQWPMCQ-UHFFFAOYSA-N 0.000 claims description 2
- DLACLAQITXYWRX-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-chloro-3-fluorobenzamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=C(F)C(Cl)=CC=2)=CC=C1OCCN DLACLAQITXYWRX-UHFFFAOYSA-N 0.000 claims description 2
- VLLQMHRVZHBODM-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-cyanobenzamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=CC(=CC=2)C#N)=CC=C1OCCN VLLQMHRVZHBODM-UHFFFAOYSA-N 0.000 claims description 2
- FZSQHSAWFWISBF-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-ethylbenzamide Chemical compound C1=CC(CC)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 FZSQHSAWFWISBF-UHFFFAOYSA-N 0.000 claims description 2
- RJTDCESQPZRXMX-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-fluoro-3-(trifluoromethyl)benzamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=C(C(F)=CC=2)C(F)(F)F)=CC=C1OCCN RJTDCESQPZRXMX-UHFFFAOYSA-N 0.000 claims description 2
- UHMNIBMDXRIFMR-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-fluoro-3-methoxybenzamide Chemical compound C1=C(F)C(OC)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1 UHMNIBMDXRIFMR-UHFFFAOYSA-N 0.000 claims description 2
- QFOGWUZTVRIHOE-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-methoxy-2-methylbenzamide Chemical compound CC1=CC(OC)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 QFOGWUZTVRIHOE-UHFFFAOYSA-N 0.000 claims description 2
- QGVRXVXDEUOQCB-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-methoxy-3,5-dimethylbenzamide Chemical compound C1=C(C)C(OC)=C(C)C=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 QGVRXVXDEUOQCB-UHFFFAOYSA-N 0.000 claims description 2
- KXRSDSYRJZFVFG-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-methoxy-3-(trifluoromethyl)benzamide Chemical compound C1=C(C(F)(F)F)C(OC)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 KXRSDSYRJZFVFG-UHFFFAOYSA-N 0.000 claims description 2
- NWNYDQVKZRBSQC-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-methoxy-3-methylbenzamide Chemical compound C1=C(C)C(OC)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 NWNYDQVKZRBSQC-UHFFFAOYSA-N 0.000 claims description 2
- BKVPLWCPFRGJRU-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-methyl-1,3-thiazole-5-carboxamide Chemical compound N1=CSC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1C BKVPLWCPFRGJRU-UHFFFAOYSA-N 0.000 claims description 2
- AVQSCPVVQADPIW-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-methyl-2,3-dihydro-1,4-benzoxazine-7-carboxamide Chemical compound C=1C=C2N(C)CCOC2=CC=1C(=O)NC(C=1)=CC=C(OCCN)C=1C1=C(Cl)C=NN1C AVQSCPVVQADPIW-UHFFFAOYSA-N 0.000 claims description 2
- DRFIXWGUBSHODF-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-propan-2-yloxybenzamide Chemical compound C1=CC(OC(C)C)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 DRFIXWGUBSHODF-UHFFFAOYSA-N 0.000 claims description 2
- HPSDHMXGICIXTD-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4-thiophen-2-ylbenzamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=CC(=CC=2)C=2SC=CC=2)=CC=C1OCCN HPSDHMXGICIXTD-UHFFFAOYSA-N 0.000 claims description 2
- HTCMGFVWOWZUJX-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-(4-chlorophenyl)-2-(trifluoromethyl)furan-3-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C2=C(OC(=C2)C=2C=CC(Cl)=CC=2)C(F)(F)F)=CC=C1OCCN HTCMGFVWOWZUJX-UHFFFAOYSA-N 0.000 claims description 2
- OHRSCRQDYKJWFQ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-bromopyridine-3-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=C(Br)C=NC=2)=CC=C1OCCN OHRSCRQDYKJWFQ-UHFFFAOYSA-N 0.000 claims description 2
- XCAHGQKNSPKSCD-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-chloro-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxamide Chemical compound CN1N=C(C(F)(F)F)C(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1Cl XCAHGQKNSPKSCD-UHFFFAOYSA-N 0.000 claims description 2
- HPRZAGHKEDZDGK-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-chlorothiophene-2-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2SC(Cl)=CC=2)=CC=C1OCCN HPRZAGHKEDZDGK-UHFFFAOYSA-N 0.000 claims description 2
- IFSMIRWBAQRYMF-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-methoxy-2-(2,2,2-trifluoroethoxy)benzamide Chemical compound COC1=CC=C(OCC(F)(F)F)C(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1 IFSMIRWBAQRYMF-UHFFFAOYSA-N 0.000 claims description 2
- WWHKKSSJTSNSOH-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide Chemical compound O1C(C)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=N1 WWHKKSSJTSNSOH-UHFFFAOYSA-N 0.000 claims description 2
- ODOINOSGJJNFLX-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-methyl-1,2-oxazole-4-carboxamide Chemical compound O1N=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1C ODOINOSGJJNFLX-UHFFFAOYSA-N 0.000 claims description 2
- ZYQXJZKTDHAKKO-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-methyl-1h-pyrazole-3-carboxamide Chemical compound N1C(C)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=N1 ZYQXJZKTDHAKKO-UHFFFAOYSA-N 0.000 claims description 2
- SQKGZZNQMRDPQT-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-methylpyrazine-2-carboxamide Chemical compound C1=NC(C)=CN=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 SQKGZZNQMRDPQT-UHFFFAOYSA-N 0.000 claims description 2
- PDANYVOFMLAKLK-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-methylpyridine-3-carboxamide Chemical compound CC1=CN=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2Cl)C)=C1 PDANYVOFMLAKLK-UHFFFAOYSA-N 0.000 claims description 2
- ZESOETOZBSNNQL-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-methylthiophene-2-carboxamide Chemical compound S1C(C)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 ZESOETOZBSNNQL-UHFFFAOYSA-N 0.000 claims description 2
- MBWKYWRLYQYPCR-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-propan-2-yl-1h-pyrazole-3-carboxamide Chemical compound N1N=C(C(C)C)C=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 MBWKYWRLYQYPCR-UHFFFAOYSA-N 0.000 claims description 2
- RSKPTBTUHSKHNY-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-tert-butyl-2-methylpyrazole-3-carboxamide Chemical compound CN1N=C(C(C)(C)C)C=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 RSKPTBTUHSKHNY-UHFFFAOYSA-N 0.000 claims description 2
- IAONCWDDZATVTC-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-6-oxopyran-3-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C2=COC(=O)C=C2)=CC=C1OCCN IAONCWDDZATVTC-UHFFFAOYSA-N 0.000 claims description 2
- FJBWONWMUJJYKF-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-6-pyrrolidin-1-ylpyridine-3-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=NC(=CC=2)N2CCCC2)=CC=C1OCCN FJBWONWMUJJYKF-UHFFFAOYSA-N 0.000 claims description 2
- JEPIJIMOPQDAEL-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]adamantane-1-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C23CC4CC(CC(C4)C2)C3)=CC=C1OCCN JEPIJIMOPQDAEL-UHFFFAOYSA-N 0.000 claims description 2
- VHYSUYRMTNXPFO-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]cinnoline-4-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C3=CC=CC=C3N=NC=2)=CC=C1OCCN VHYSUYRMTNXPFO-UHFFFAOYSA-N 0.000 claims description 2
- NUUDYWZQAXNGOA-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]cyclopentanecarboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C2CCCC2)=CC=C1OCCN NUUDYWZQAXNGOA-UHFFFAOYSA-N 0.000 claims description 2
- QNHYQCZLWPAWSC-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]cyclopropanecarboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C2CC2)=CC=C1OCCN QNHYQCZLWPAWSC-UHFFFAOYSA-N 0.000 claims description 2
- MBCVIJQKWGHMBZ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]oxolane-2-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C2OCCC2)=CC=C1OCCN MBCVIJQKWGHMBZ-UHFFFAOYSA-N 0.000 claims description 2
- NHSRLLLZGZUGFS-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]pyridine-2-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2N=CC=CC=2)=CC=C1OCCN NHSRLLLZGZUGFS-UHFFFAOYSA-N 0.000 claims description 2
- IAHQANOCGKYFKI-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]pyridine-3-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=NC=CC=2)=CC=C1OCCN IAHQANOCGKYFKI-UHFFFAOYSA-N 0.000 claims description 2
- PJHOHIVZVFUGSC-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]pyridine-4-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=CN=CC=2)=CC=C1OCCN PJHOHIVZVFUGSC-UHFFFAOYSA-N 0.000 claims description 2
- TWRSMNFDLQTLMY-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]quinoline-2-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2N=C3C=CC=CC3=CC=2)=CC=C1OCCN TWRSMNFDLQTLMY-UHFFFAOYSA-N 0.000 claims description 2
- CRFMRQSPCNOQEF-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]thiophene-2-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2SC=CC=2)=CC=C1OCCN CRFMRQSPCNOQEF-UHFFFAOYSA-N 0.000 claims description 2
- PCMSTIMMQFLTBR-NRFANRHFSA-N n-[4-[(2r)-2-amino-2-cyclohexylethoxy]-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]pyridine-3-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=NC=CC=2)=CC=C1OC[C@H](N)C1CCCCC1 PCMSTIMMQFLTBR-NRFANRHFSA-N 0.000 claims description 2
- JQKUZHLLVPBOMZ-INIZCTEOSA-N n-[4-[(2r)-2-amino-3-methylbutoxy]-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide Chemical compound C1=C(C=2N(N=CC=2Cl)C)C(OC[C@H](N)C(C)C)=CC=C1NC(=O)C=1C=C(C)ON=1 JQKUZHLLVPBOMZ-INIZCTEOSA-N 0.000 claims description 2
- YTMWJRGRHVWANX-SFHVURJKSA-N n-[4-[(2r)-2-amino-3-methylbutoxy]-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]pyridine-3-carboxamide Chemical compound C1=C(C=2N(N=CC=2Cl)C)C(OC[C@H](N)C(C)C)=CC=C1NC(=O)C1=CC=CN=C1 YTMWJRGRHVWANX-SFHVURJKSA-N 0.000 claims description 2
- IWYLLYFDGKLEGM-CQSZACIVSA-N n-[4-[(2r)-2-amino-4-methylpentoxy]-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide Chemical compound C1=C(C=2N(N=CC=2Cl)C)C(OC[C@H](N)CC(C)C)=CC=C1NC(=O)C=1C=C(C)ON=1 IWYLLYFDGKLEGM-CQSZACIVSA-N 0.000 claims description 2
- SAPUWJVJZKUMNZ-MRXNPFEDSA-N n-[4-[(2r)-2-amino-4-methylpentoxy]-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]pyridine-3-carboxamide Chemical compound C1=C(C=2N(N=CC=2Cl)C)C(OC[C@H](N)CC(C)C)=CC=C1NC(=O)C1=CC=CN=C1 SAPUWJVJZKUMNZ-MRXNPFEDSA-N 0.000 claims description 2
- KYFOFOZLOKJMBK-GFCCVEGCSA-N n-[4-[(2r)-2-aminopropoxy]-3-(2-methylpyrazol-3-yl)phenyl]-2,2-difluoro-1,3-benzodioxole-4-carboxamide Chemical compound C[C@@H](N)COC1=CC=C(NC(=O)C=2C=3OC(F)(F)OC=3C=CC=2)C=C1C1=CC=NN1C KYFOFOZLOKJMBK-GFCCVEGCSA-N 0.000 claims description 2
- XMPHBSMAPNDLKA-GFCCVEGCSA-N n-[4-[(2r)-2-aminopropoxy]-3-(2-methylpyrazol-3-yl)phenyl]-2,2-difluoro-1,3-benzodioxole-5-carboxamide Chemical compound C[C@@H](N)COC1=CC=C(NC(=O)C=2C=C3OC(F)(F)OC3=CC=2)C=C1C1=CC=NN1C XMPHBSMAPNDLKA-GFCCVEGCSA-N 0.000 claims description 2
- TZUVBDCQWXITDD-SNVBAGLBSA-N n-[4-[(2r)-2-aminopropoxy]-3-(2-methylpyrazol-3-yl)phenyl]-2,5-dichlorothiophene-3-carboxamide Chemical compound C1=C(C=2N(N=CC=2)C)C(OC[C@H](N)C)=CC=C1NC(=O)C=1C=C(Cl)SC=1Cl TZUVBDCQWXITDD-SNVBAGLBSA-N 0.000 claims description 2
- LIZLIOCQVRKXDM-CQSZACIVSA-N n-[4-[(2r)-2-aminopropoxy]-3-(2-methylpyrazol-3-yl)phenyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OC[C@@H](C)N)=CC=2)C=2N(N=CC=2)C)=C1 LIZLIOCQVRKXDM-CQSZACIVSA-N 0.000 claims description 2
- LGOIBJXOSJNBMH-CYBMUJFWSA-N n-[4-[(2r)-2-aminopropoxy]-3-(2-methylpyrazol-3-yl)phenyl]-4-(trifluoromethoxy)benzamide Chemical compound C1=C(C=2N(N=CC=2)C)C(OC[C@H](N)C)=CC=C1NC(=O)C1=CC=C(OC(F)(F)F)C=C1 LGOIBJXOSJNBMH-CYBMUJFWSA-N 0.000 claims description 2
- LBHWGACQABEBQM-GFCCVEGCSA-N n-[4-[(2r)-2-aminopropoxy]-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2-fluoro-4-methoxybenzamide Chemical compound FC1=CC(OC)=CC=C1C(=O)NC1=CC=C(OC[C@@H](C)N)C(C=2N(N=CC=2Cl)C)=C1 LBHWGACQABEBQM-GFCCVEGCSA-N 0.000 claims description 2
- PCMSTIMMQFLTBR-OAQYLSRUSA-N n-[4-[(2s)-2-amino-2-cyclohexylethoxy]-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]pyridine-3-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=NC=CC=2)=CC=C1OC[C@@H](N)C1CCCCC1 PCMSTIMMQFLTBR-OAQYLSRUSA-N 0.000 claims description 2
- FGYAZDIZEZZQIA-LJQANCHMSA-N n-[4-[(2s)-2-amino-3,3-dimethylbutoxy]-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]pyridine-3-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=NC=CC=2)=CC=C1OC[C@@H](N)C(C)(C)C FGYAZDIZEZZQIA-LJQANCHMSA-N 0.000 claims description 2
- BURNDFYYWQVPLS-KRWDZBQOSA-N n-[4-[(2s)-2-amino-3-cyclohexylpropoxy]-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide Chemical compound O1C(C)=CC(C(=O)NC=2C=C(C(OC[C@@H](N)CC3CCCCC3)=CC=2)C=2N(N=CC=2Cl)C)=N1 BURNDFYYWQVPLS-KRWDZBQOSA-N 0.000 claims description 2
- RNYIYELWWZOTIJ-HXUWFJFHSA-N n-[4-[(2s)-2-amino-3-methylbutoxy]-3-(2-methylpyrazol-3-yl)phenyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OC[C@@H](N)C(C)C)=CC=2)C=2N(N=CC=2)C)=C1 RNYIYELWWZOTIJ-HXUWFJFHSA-N 0.000 claims description 2
- YTMWJRGRHVWANX-GOSISDBHSA-N n-[4-[(2s)-2-amino-3-methylbutoxy]-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]pyridine-3-carboxamide Chemical compound C1=C(C=2N(N=CC=2Cl)C)C(OC[C@@H](N)C(C)C)=CC=C1NC(=O)C1=CC=CN=C1 YTMWJRGRHVWANX-GOSISDBHSA-N 0.000 claims description 2
- IWYLLYFDGKLEGM-AWEZNQCLSA-N n-[4-[(2s)-2-amino-4-methylpentoxy]-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide Chemical compound C1=C(C=2N(N=CC=2Cl)C)C(OC[C@@H](N)CC(C)C)=CC=C1NC(=O)C=1C=C(C)ON=1 IWYLLYFDGKLEGM-AWEZNQCLSA-N 0.000 claims description 2
- SAPUWJVJZKUMNZ-INIZCTEOSA-N n-[4-[(2s)-2-amino-4-methylpentoxy]-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]pyridine-3-carboxamide Chemical compound C1=C(C=2N(N=CC=2Cl)C)C(OC[C@@H](N)CC(C)C)=CC=C1NC(=O)C1=CC=CN=C1 SAPUWJVJZKUMNZ-INIZCTEOSA-N 0.000 claims description 2
- ZXRDPRRFWCYPAE-AWEZNQCLSA-N n-[4-[(2s)-2-amino-4-methylsulfonylbutoxy]-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2-fluoro-4-methoxybenzamide Chemical compound FC1=CC(OC)=CC=C1C(=O)NC1=CC=C(OC[C@@H](N)CCS(C)(=O)=O)C(C=2N(N=CC=2Cl)C)=C1 ZXRDPRRFWCYPAE-AWEZNQCLSA-N 0.000 claims description 2
- KYFOFOZLOKJMBK-LBPRGKRZSA-N n-[4-[(2s)-2-aminopropoxy]-3-(2-methylpyrazol-3-yl)phenyl]-2,2-difluoro-1,3-benzodioxole-4-carboxamide Chemical compound C[C@H](N)COC1=CC=C(NC(=O)C=2C=3OC(F)(F)OC=3C=CC=2)C=C1C1=CC=NN1C KYFOFOZLOKJMBK-LBPRGKRZSA-N 0.000 claims description 2
- XMPHBSMAPNDLKA-LBPRGKRZSA-N n-[4-[(2s)-2-aminopropoxy]-3-(2-methylpyrazol-3-yl)phenyl]-2,2-difluoro-1,3-benzodioxole-5-carboxamide Chemical compound C[C@H](N)COC1=CC=C(NC(=O)C=2C=C3OC(F)(F)OC3=CC=2)C=C1C1=CC=NN1C XMPHBSMAPNDLKA-LBPRGKRZSA-N 0.000 claims description 2
- TZUVBDCQWXITDD-JTQLQIEISA-N n-[4-[(2s)-2-aminopropoxy]-3-(2-methylpyrazol-3-yl)phenyl]-2,5-dichlorothiophene-3-carboxamide Chemical compound C1=C(C=2N(N=CC=2)C)C(OC[C@@H](N)C)=CC=C1NC(=O)C=1C=C(Cl)SC=1Cl TZUVBDCQWXITDD-JTQLQIEISA-N 0.000 claims description 2
- LIZLIOCQVRKXDM-AWEZNQCLSA-N n-[4-[(2s)-2-aminopropoxy]-3-(2-methylpyrazol-3-yl)phenyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OC[C@H](C)N)=CC=2)C=2N(N=CC=2)C)=C1 LIZLIOCQVRKXDM-AWEZNQCLSA-N 0.000 claims description 2
- LGOIBJXOSJNBMH-ZDUSSCGKSA-N n-[4-[(2s)-2-aminopropoxy]-3-(2-methylpyrazol-3-yl)phenyl]-4-(trifluoromethoxy)benzamide Chemical compound C1=C(C=2N(N=CC=2)C)C(OC[C@@H](N)C)=CC=C1NC(=O)C1=CC=C(OC(F)(F)F)C=C1 LGOIBJXOSJNBMH-ZDUSSCGKSA-N 0.000 claims description 2
- LBHWGACQABEBQM-LBPRGKRZSA-N n-[4-[(2s)-2-aminopropoxy]-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2-fluoro-4-methoxybenzamide Chemical compound FC1=CC(OC)=CC=C1C(=O)NC1=CC=C(OC[C@H](C)N)C(C=2N(N=CC=2Cl)C)=C1 LBHWGACQABEBQM-LBPRGKRZSA-N 0.000 claims description 2
- JELSKVOBDHXJPF-JTQLQIEISA-N n-[4-[(2s)-2-aminopropoxy]-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide Chemical compound C1=C(C=2N(N=CC=2Cl)C)C(OC[C@@H](N)C)=CC=C1NC(=O)C=1C=C(C)ON=1 JELSKVOBDHXJPF-JTQLQIEISA-N 0.000 claims description 2
- AKAWKIQTHRPNJJ-UHFFFAOYSA-N n-[4-[2-(hexanoylamino)ethoxy]-3-(2-methylpyrazol-3-yl)phenyl]-3-methoxybenzamide Chemical compound C1=C(C=2N(N=CC=2)C)C(OCCNC(=O)CCCCC)=CC=C1NC(=O)C1=CC=CC(OC)=C1 AKAWKIQTHRPNJJ-UHFFFAOYSA-N 0.000 claims description 2
- VCELSSRPZYRHMN-UHFFFAOYSA-N n-[4-[2-[[2-(dimethylamino)acetyl]amino]ethoxy]-3-(2-methylpyrazol-3-yl)phenyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OCCNC(=O)CN(C)C)=CC=2)C=2N(N=CC=2)C)=C1 VCELSSRPZYRHMN-UHFFFAOYSA-N 0.000 claims description 2
- 125000004159 quinolin-2-yl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C([H])C(*)=NC2=C1[H] 0.000 claims description 2
- 125000004192 tetrahydrofuran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 claims description 2
- 125000006583 (C1-C3) haloalkyl group Chemical group 0.000 claims 6
- 125000006594 (C1-C3) alkylsulfony group Chemical group 0.000 claims 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims 2
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 claims 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
- QHOOQLXZKWMYCC-UHFFFAOYSA-N 2-(2-methoxyphenyl)acetamide Chemical compound COC1=CC=CC=C1CC(N)=O QHOOQLXZKWMYCC-UHFFFAOYSA-N 0.000 claims 1
- ZFEHQZVNKOESSZ-UHFFFAOYSA-N 4,5-dichloro-1,2-thiazole-3-carboxylic acid Chemical compound OC(=O)C1=NSC(Cl)=C1Cl ZFEHQZVNKOESSZ-UHFFFAOYSA-N 0.000 claims 1
- FBTMKHLXNPEGDF-UHFFFAOYSA-N 4-acetyl-n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]benzamide Chemical compound C1=CC(C(=O)C)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 FBTMKHLXNPEGDF-UHFFFAOYSA-N 0.000 claims 1
- BQUIEVOFWHVZAW-UHFFFAOYSA-N 5-(4-chlorophenyl)-2-(trifluoromethyl)furan-3-carboxylic acid Chemical compound O1C(C(F)(F)F)=C(C(=O)O)C=C1C1=CC=C(Cl)C=C1 BQUIEVOFWHVZAW-UHFFFAOYSA-N 0.000 claims 1
- 125000005605 benzo group Chemical group 0.000 claims 1
- 125000004212 difluorophenyl group Chemical group 0.000 claims 1
- 125000004438 haloalkoxy group Chemical group 0.000 claims 1
- 125000004284 isoxazol-3-yl group Chemical group [H]C1=C([H])C(*)=NO1 0.000 claims 1
- ZNJHDDAVUNSLQM-UHFFFAOYSA-N n-[4-(2-amino-2-iminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2-fluoro-4-methoxybenzamide Chemical compound FC1=CC(OC)=CC=C1C(=O)NC1=CC=C(OCC(N)=N)C(C=2N(N=CC=2Cl)C)=C1 ZNJHDDAVUNSLQM-UHFFFAOYSA-N 0.000 claims 1
- XIACWRKWIHLIMW-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(5-methyltetrazol-1-yl)acetamide Chemical compound CC1=NN=NN1CC(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 XIACWRKWIHLIMW-UHFFFAOYSA-N 0.000 claims 1
- NOJJCFCOUOUGNY-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-fluoro-4-methylbenzamide Chemical compound C1=C(F)C(C)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 NOJJCFCOUOUGNY-UHFFFAOYSA-N 0.000 claims 1
- WJRDLANWRILXSV-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-3-methoxy-4-methylbenzamide Chemical compound C1=C(C)C(OC)=CC(C(=O)NC=2C=C(C(OCCN)=CC=2)C=2N(N=CC=2)C)=C1 WJRDLANWRILXSV-UHFFFAOYSA-N 0.000 claims 1
- QUNPQNKVGBNLTL-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-2,3-dihydro-1,4-benzodioxine-5-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=3OCCOC=3C=CC=2)=CC=C1OCCN QUNPQNKVGBNLTL-UHFFFAOYSA-N 0.000 claims 1
- XRIDRYVMIZRELG-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-3-chloro-4-methoxybenzamide Chemical compound C1=C(Cl)C(OC)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2Cl)C)=C1 XRIDRYVMIZRELG-UHFFFAOYSA-N 0.000 claims 1
- PYLPCBHMXVMNJL-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-6-morpholin-4-ylpyridine-3-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C=NC(=CC=2)N2CCOCC2)=CC=C1OCCN PYLPCBHMXVMNJL-UHFFFAOYSA-N 0.000 claims 1
- 125000001188 haloalkyl group Chemical group 0.000 description 12
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 4
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 2
- 125000004441 haloalkylsulfonyl group Chemical group 0.000 description 2
- VCLSWKVAHAJSFL-UHFFFAOYSA-N 2,3-dihydro-1,4-benzodioxine-5-carboxylic acid Chemical compound O1CCOC2=C1C=CC=C2C(=O)O VCLSWKVAHAJSFL-UHFFFAOYSA-N 0.000 description 1
- PSXAYXIIZJMIJH-UHFFFAOYSA-N 5,6-dihydro-4h-pyrimidine Chemical compound C1C[N]C=NC1 PSXAYXIIZJMIJH-UHFFFAOYSA-N 0.000 description 1
- OGGKXAITAUFYRQ-UHFFFAOYSA-N n-[4-(2-amino-2-methylpropoxy)-3-(4-bromo-2-methylpyrazol-3-yl)phenyl]-4-methoxybenzamide Chemical compound C1=CC(OC)=CC=C1C(=O)NC1=CC=C(OCC(C)(C)N)C(C=2N(N=CC=2Br)C)=C1 OGGKXAITAUFYRQ-UHFFFAOYSA-N 0.000 description 1
- KXYXMPNRNZLZRR-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-2-(2-methoxyphenyl)acetamide Chemical compound COC1=CC=CC=C1CC(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 KXYXMPNRNZLZRR-UHFFFAOYSA-N 0.000 description 1
- IRTPWAOZNAOWQL-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-4-methoxy-3-methylbenzamide Chemical compound C1=C(C)C(OC)=CC=C1C(=O)NC1=CC=C(OCCN)C(C=2N(N=CC=2)C)=C1 IRTPWAOZNAOWQL-UHFFFAOYSA-N 0.000 description 1
- XBSAKQQDEJLTGV-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(2-methylpyrazol-3-yl)phenyl]-5-(4-chlorophenyl)-2-(trifluoromethyl)furan-3-carboxamide Chemical compound CN1N=CC=C1C1=CC(NC(=O)C2=C(OC(=C2)C=2C=CC(Cl)=CC=2)C(F)(F)F)=CC=C1OCCN XBSAKQQDEJLTGV-UHFFFAOYSA-N 0.000 description 1
- XJSMMZDZTNXIFZ-UHFFFAOYSA-N n-[4-(2-aminoethoxy)-3-(4-chloro-2-methylpyrazol-3-yl)phenyl]-4,5-dichloro-1,2-thiazole-3-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=CC(NC(=O)C=2C(=C(Cl)SN=2)Cl)=CC=C1OCCN XJSMMZDZTNXIFZ-UHFFFAOYSA-N 0.000 description 1
- JQSLXLHTCBZARJ-QHCPKHFHSA-N n-[4-[2-[[(2s)-2-acetamido-4-methylsulfanylbutanoyl]amino]ethoxy]-3-(2-methylpyrazol-3-yl)phenyl]-3-methoxybenzamide Chemical compound COC1=CC=CC(C(=O)NC=2C=C(C(OCCNC(=O)[C@H](CCSC)NC(C)=O)=CC=2)C=2N(N=CC=2)C)=C1 JQSLXLHTCBZARJ-QHCPKHFHSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80179906P | 2006-05-18 | 2006-05-18 | |
| US60/801,799 | 2006-05-18 | ||
| PCT/US2007/011834 WO2007136703A1 (en) | 2006-05-18 | 2007-05-17 | Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009537545A JP2009537545A (ja) | 2009-10-29 |
| JP2009537545A5 true JP2009537545A5 (OSRAM) | 2010-06-24 |
| JP5406018B2 JP5406018B2 (ja) | 2014-02-05 |
Family
ID=38513741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009511067A Expired - Fee Related JP5406018B2 (ja) | 2006-05-18 | 2007-05-17 | 5−ht2aセロトニンレセプターに関連する障害の処置に有用な5−ht2aセロトニンレセプターのモジュレーターとしての1級アミン、およびその誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (7) | USRE45336E1 (OSRAM) |
| EP (1) | EP2018371B1 (OSRAM) |
| JP (1) | JP5406018B2 (OSRAM) |
| ES (1) | ES2536762T3 (OSRAM) |
| WO (1) | WO2007136703A1 (OSRAM) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0412263B1 (pt) | 2003-07-22 | 2019-10-15 | Arena Pharmaceuticals, Inc. | Derivados de diaril e aril heteroaril uréia, uso e composição farmacêutica contendo os mesmos, bem como processo para preparação da dita composição |
| WO2005103011A1 (en) * | 2004-03-23 | 2005-11-03 | Arena Pharmaceuticals, Inc. | Processes for preparing substituted n-aryl-n’-[3-(1h-pyrazol-5-yl) phenyl] ureas and intermediates thereof |
| SA05260357B1 (ar) * | 2004-11-19 | 2008-09-08 | ارينا فارماسيتو تيكالز ، أنك | مشتقات 3_فينيل_بيرازول كمعدلات لمستقبل سيروتينين 5_ht2a مفيدة في علاج الاضطرابات المتعلقه به |
| EP2018371B1 (en) | 2006-05-18 | 2015-03-04 | Arena Pharmaceuticals, Inc. | Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| CN102827081A (zh) | 2006-05-18 | 2012-12-19 | 艾尼纳制药公司 | 用作5-ht2a 血清素受体调节剂的苯基-吡唑的晶型和其制备方法 |
| EP2027119A2 (en) | 2006-05-18 | 2009-02-25 | Arena Pharmaceuticals, Inc. | Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| TWI415845B (zh) | 2006-10-03 | 2013-11-21 | Arena Pharm Inc | 用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物 |
| EP2190844B3 (en) | 2007-08-15 | 2013-07-17 | Arena Pharmaceuticals, Inc. | Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| EP2222639A1 (en) * | 2007-11-21 | 2010-09-01 | Decode Genetics EHF | Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
| CA2741731A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto |
| WO2011075596A1 (en) | 2009-12-18 | 2011-06-23 | Arena Pharmaceuticals, Inc. | Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| WO2011156321A1 (en) | 2010-06-07 | 2011-12-15 | Novomedix, Llc | Furanyl compounds and the use thereof |
| AU2011329233A1 (en) | 2010-11-15 | 2013-05-23 | Abbvie Deutschland Gmbh & Co Kg | NAMPT and ROCK inhibitors |
| WO2015100225A1 (en) | 2013-12-27 | 2015-07-02 | Novus International Inc. | Ethoxylated surfactants |
| EP4119141A1 (en) | 2015-06-12 | 2023-01-18 | Axovant Sciences GmbH | Nelotanserin for the prophylaxis and treatment of rem sleep behavior disorder |
| EP3322415A4 (en) | 2015-07-15 | 2019-03-13 | Axovant Sciences GmbH | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR FOR PROPHYLAXIS AND TREATMENT OF HALLUCINATIONS RELATED TO A NEUROGENERATIVE DISEASE |
| EP3426636B1 (en) * | 2016-03-07 | 2021-12-29 | Northwestern University | Specific 2-(4-(phenoxy)-1h-pyrazol-3-yl)phenol derivatives as inhibitors of c-myc/dna binding activity for treating cancer |
| US11142504B2 (en) | 2016-03-07 | 2021-10-12 | Northwestern University | Substituted heterocycles as c-MYC targeting agents |
| US10368881B2 (en) | 2016-06-03 | 2019-08-06 | Quandary Medical, Llc | Method and apparatus for minimally invasive posterolateral spinal fusion |
| US10584306B2 (en) | 2017-08-11 | 2020-03-10 | Board Of Regents Of The University Of Oklahoma | Surfactant microemulsions |
| WO2019060298A1 (en) | 2017-09-19 | 2019-03-28 | Neuroenhancement Lab, LLC | METHOD AND APPARATUS FOR NEURO-ACTIVATION |
| US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
| US11478603B2 (en) | 2017-12-31 | 2022-10-25 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
| US12280219B2 (en) | 2017-12-31 | 2025-04-22 | NeuroLight, Inc. | Method and apparatus for neuroenhancement to enhance emotional response |
| US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
| CN114174265A (zh) * | 2018-08-31 | 2022-03-11 | 西北大学 | 作为c-MYC靶向剂的取代的杂环 |
| CN113382683A (zh) | 2018-09-14 | 2021-09-10 | 纽罗因恒思蒙特实验有限责任公司 | 改善睡眠的系统和方法 |
| WO2020257261A1 (en) | 2019-06-17 | 2020-12-24 | Northwestern University | SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS |
| WO2022093850A1 (en) * | 2020-10-27 | 2022-05-05 | Arena Pharmaceuticals, Inc. | Isoxazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| CA3199274A1 (en) * | 2020-10-27 | 2022-05-05 | Arena Pharmaceuticals, Inc. | Pyrimidine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| KR102707476B1 (ko) | 2021-01-28 | 2024-09-20 | 주식회사 파미노젠 | 피라졸-카르복스아미드 유도체 화합물 및 이의 용도 |
| WO2023288027A1 (en) * | 2021-07-14 | 2023-01-19 | Northeastern University | Serotonin 5-ht2a, 5-ht2b, and 5-ht2c receptor inverse agonists |
| WO2023067520A1 (en) * | 2021-10-22 | 2023-04-27 | Arena Pharmaceuticals, Inc. | Crystalline forms and processes for the preparation of pyrimidine derivatives useful as modulators of the 5-ht 2a serotonin receptor |
| TW202330546A (zh) * | 2021-12-31 | 2023-08-01 | 香港商愛科諾生物醫藥(香港)有限公司 | 具有irak4抑制活性的化合物,包含其的藥物組合物,及其應用 |
| JPWO2024122617A1 (OSRAM) | 2022-12-08 | 2024-06-13 |
Family Cites Families (96)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4099012A (en) | 1975-08-28 | 1978-07-04 | Ciba-Geigy Corporation | 2-pyrazolyl-benzophenones |
| DE2926517A1 (de) | 1979-06-30 | 1981-01-15 | Beiersdorf Ag | Substituierte 3-aryl-pyrazole und 5-aryl-isoxazole und verfahren zu ihrer herstellung |
| DE2928485A1 (de) | 1979-07-14 | 1981-01-29 | Bayer Ag | Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen |
| US4985352A (en) | 1988-02-29 | 1991-01-15 | The Trustees Of Columbia University In The City Of New York | DNA encoding serotonin 1C (5HT1c) receptor, isolated 5HT1c receptor, mammalian cells expressing same and uses thereof |
| US5661024A (en) | 1989-10-31 | 1997-08-26 | Synaptic Pharmaceutical Corporation | DNA encoding a human serotonic (5-HT2) receptor and uses thereof |
| US5077409A (en) | 1990-05-04 | 1991-12-31 | American Cyanamid Company | Method of preparing bis-aryl amide and urea antagonists of platelet activating factor |
| US5128351A (en) | 1990-05-04 | 1992-07-07 | American Cyanamid Company | Bis-aryl amide and urea antagonists of platelet activating factor |
| FR2682379B1 (fr) | 1991-10-09 | 1994-02-11 | Rhone Poulenc Agrochimie | Nouveaux phenylpyrazoles fongicides. |
| FR2690440B1 (fr) | 1992-04-27 | 1995-05-19 | Rhone Poulenc Agrochimie | Arylpyrazoles fongicides. |
| US5905080A (en) | 1993-08-20 | 1999-05-18 | Smithkline Beecham, P.L.C. | Amide and urea derivatives as 5HT1D receptor antagonists |
| US5739135A (en) | 1993-09-03 | 1998-04-14 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
| FR2722369B1 (fr) | 1994-07-13 | 1998-07-10 | Rhone Poulenc Agrochimie | Compositions fongicides a base de derives 3-phenyl-pyrazoles pour le traitement du materiel vegetal de multiplication, nouveaux derives 3-phenyl-pyrazoles et leurs applications fongicides |
| EP0784612A1 (en) | 1994-10-04 | 1997-07-23 | Fujisawa Pharmaceutical Co., Ltd. | Urea derivatives and their use as acat-inhibitors |
| CN1151147C (zh) | 1995-02-02 | 2004-05-26 | 史密丝克莱恩比彻姆有限公司 | 作为5-ht受体拮抗剂的吲哚衍生物 |
| EP0809492A4 (en) | 1995-02-17 | 2007-01-24 | Smithkline Beecham Corp | IL-8 RECEPTOR ANTAGONISTS |
| AU6526896A (en) | 1995-07-22 | 1997-02-18 | Rhone-Poulenc Rorer Limited | Substituted aromatic compounds and their pharmaceutical use |
| US6054472A (en) | 1996-04-23 | 2000-04-25 | Vertex Pharmaceuticals, Incorporated | Inhibitors of IMPDH enzyme |
| US6005008A (en) | 1996-02-16 | 1999-12-21 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| GB9607219D0 (en) | 1996-04-04 | 1996-06-12 | Smithkline Beecham Plc | Novel compounds |
| WO1997045400A1 (en) | 1996-05-24 | 1997-12-04 | Neurosearch A/S | Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| AU2962297A (en) | 1996-05-24 | 1998-01-05 | Neurosearch A/S | Phenyl derivatives useful as blockers of chloride channels |
| KR20000022273A (ko) | 1996-06-27 | 2000-04-25 | 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 | Il-8 수용체 길항제 |
| JP2001508767A (ja) | 1996-12-02 | 2001-07-03 | 藤沢薬品工業株式会社 | 5―ht拮抗作用を有するインドール―ウレア誘導体 |
| US5760246A (en) | 1996-12-17 | 1998-06-02 | Biller; Scott A. | Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| US6541209B1 (en) | 1997-04-14 | 2003-04-01 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| SK282818B6 (sk) | 1997-04-22 | 2002-12-03 | Neurosearch A/S | Substituované fenylderiváty, ich príprava, použitie a farmaceutický prípravok |
| US6696475B2 (en) | 1997-04-22 | 2004-02-24 | Neurosearch A/S | Substituted phenyl derivatives, their preparation and use |
| CA2294064A1 (en) | 1997-07-29 | 1999-02-11 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
| JP4555468B2 (ja) | 1997-10-31 | 2010-09-29 | アベンテイス・フアルマ・リミテツド | 置換アニリド |
| US7517880B2 (en) | 1997-12-22 | 2009-04-14 | Bayer Pharmaceuticals Corporation | Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| EP1042305B1 (en) | 1997-12-22 | 2005-06-08 | Bayer Pharmaceuticals Corp. | INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
| CA2315646C (en) | 1997-12-22 | 2010-02-09 | Bayer Corporation | Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| US6107324A (en) | 1998-04-14 | 2000-08-22 | Arena Pharmaceuticals Inc. | 5-HT2A receptor inverse agonists |
| US6140509A (en) | 1998-06-26 | 2000-10-31 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| GB9816263D0 (en) | 1998-07-24 | 1998-09-23 | Merck Sharp & Dohme | Therapeutic agents |
| EP1123274B1 (en) | 1998-10-22 | 2004-12-29 | Neurosearch A/S | Substituted phenyl derivatives, their preparation and use |
| US6150393A (en) | 1998-12-18 | 2000-11-21 | Arena Pharmaceuticals, Inc. | Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors |
| KR20020015308A (ko) | 1999-03-26 | 2002-02-27 | 추후보정 | 아릴 치환된 피라졸, 이미다졸, 옥사졸, 티아졸 및 피롤,및 이의 용도 |
| GB9909409D0 (en) | 1999-04-24 | 1999-06-23 | Zeneca Ltd | Chemical compounds |
| WO2001021160A2 (en) | 1999-09-23 | 2001-03-29 | Axxima Pharmaceuticals Aktiengesellschaft | Carboxymide and aniline derivatives as selective inhibitors of pathogens |
| US6531291B1 (en) | 1999-11-10 | 2003-03-11 | The Trustees Of Columbia University In The City Of New York | Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof |
| EP1108720A1 (en) | 1999-12-08 | 2001-06-20 | Basf Aktiengesellschaft | Herbicidal 2-Pyrazolyl-6-Aryloxy-Pyri(mi)dines |
| FR2810979B1 (fr) | 2000-06-29 | 2002-08-23 | Adir | Nouveaux derives de diphenyluree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| AU2002223492A1 (en) | 2000-11-14 | 2002-05-27 | Neurosearch A/S | Use of malaria parasite anion channel blockers for treating malaria |
| AR035521A1 (es) | 2000-12-22 | 2004-06-02 | Lundbeck & Co As H | Derivados de 3-indolina y composicion farmaceutica que los comprende |
| WO2002076464A1 (en) | 2001-03-22 | 2002-10-03 | Arena Pharmaceuticals, Inc. | Anti-psychosis combination |
| ES2329881T3 (es) | 2001-09-21 | 2009-12-02 | Bristol-Myers Squibb Company | Compuestos que contienen lactama y derivados de los mismos como inhibidores del factor xa. |
| WO2003062206A2 (en) * | 2002-01-23 | 2003-07-31 | Arena Pharmaceuticals, Inc. | Small molecule modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
| WO2004028450A2 (en) | 2002-09-24 | 2004-04-08 | Arena Pharmaceuticals, Inc. | Process of making phenylpyrazoles useful as selective 5ht2a modulators and intermediates thereof |
| TW200529597A (en) | 2002-11-08 | 2005-09-01 | Interdigital Tech Corp | Composite channel quality estimation techniques for wireless receivers |
| WO2004058722A1 (en) | 2002-12-24 | 2004-07-15 | Arena Pharmaceuticals, Inc. | Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a |
| CA2515544A1 (en) | 2003-02-11 | 2004-08-26 | Kemia Inc. | Compounds for the treatment of viral infection |
| JP2006521345A (ja) | 2003-03-28 | 2006-09-21 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | ニコチン性アセチルコリン受容体の正のアロステリック調節剤 |
| DE10315571A1 (de) | 2003-04-05 | 2004-10-14 | Merck Patent Gmbh | Pyrazolverbindungen |
| GB0309781D0 (en) | 2003-04-29 | 2003-06-04 | Glaxo Group Ltd | Compounds |
| BRPI0412263B1 (pt) | 2003-07-22 | 2019-10-15 | Arena Pharmaceuticals, Inc. | Derivados de diaril e aril heteroaril uréia, uso e composição farmacêutica contendo os mesmos, bem como processo para preparação da dita composição |
| US20050054691A1 (en) | 2003-08-29 | 2005-03-10 | St. Jude Children's Research Hospital | Carboxylesterase inhibitors |
| WO2005077345A1 (en) | 2004-02-03 | 2005-08-25 | Astrazeneca Ab | Compounds for the treatment of gastro-esophageal reflux disease |
| WO2005103011A1 (en) | 2004-03-23 | 2005-11-03 | Arena Pharmaceuticals, Inc. | Processes for preparing substituted n-aryl-n’-[3-(1h-pyrazol-5-yl) phenyl] ureas and intermediates thereof |
| WO2006004722A2 (en) | 2004-06-30 | 2006-01-12 | Biomol Research Laboratories, Inc. | Compositions and methods for selectively activating human sirtuins |
| JP2008509982A (ja) | 2004-08-16 | 2008-04-03 | プロシディオン・リミテッド | アリール尿素誘導体 |
| CA2584485C (en) | 2004-10-20 | 2013-12-31 | Resverlogix Corp. | Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases |
| JP2008518014A (ja) | 2004-10-27 | 2008-05-29 | ニューロゲン コーポレイション | Cb1拮抗薬としてのジアリール尿素 |
| WO2006049734A2 (en) | 2004-10-29 | 2006-05-11 | Hypnion, Inc. | Quetiapine analogs and methods of use thereof |
| SA05260357B1 (ar) | 2004-11-19 | 2008-09-08 | ارينا فارماسيتو تيكالز ، أنك | مشتقات 3_فينيل_بيرازول كمعدلات لمستقبل سيروتينين 5_ht2a مفيدة في علاج الاضطرابات المتعلقه به |
| WO2006060654A2 (en) | 2004-12-01 | 2006-06-08 | Divergence, Inc. | Pesticidal compositions and methods |
| GB0426313D0 (en) | 2004-12-01 | 2005-01-05 | Merck Sharp & Dohme | Therapeutic agents |
| US20080015223A1 (en) | 2004-12-03 | 2008-01-17 | Arena Pharmaceuticals, Inc. | Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto |
| WO2006070394A1 (en) | 2004-12-28 | 2006-07-06 | Council Of Scientific And Industrial Research | Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors |
| EP1858877B1 (en) | 2005-01-14 | 2014-03-12 | Gilead Connecticut, Inc. | 1,3 substituted diaryl ureas as modulators of kinase activity |
| AU2006206687A1 (en) | 2005-01-19 | 2006-07-27 | Arena Pharmaceuticals, Inc. | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis or treatment of progressive multifocal leukoencephalopathy |
| AR052886A1 (es) | 2005-01-26 | 2007-04-11 | Arena Pharm Inc | Procedimientos para preparar fenilpirazol ureas sustituidas y para la obtencion de sus intermediarios de sintesis |
| BRPI0607088A2 (pt) | 2005-01-27 | 2009-08-04 | Janssen Pharmaceutica Nv | derivados de tetrahidrofurano heterocìclico tetracìclico como inibidores de 5ht2 no tratamento de distúrbios cns |
| GT200600042A (es) | 2005-02-10 | 2006-09-27 | Aventis Pharma Inc | Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a |
| WO2006089871A2 (en) | 2005-02-23 | 2006-08-31 | Neurosearch A/S | Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias |
| GB0504828D0 (en) | 2005-03-09 | 2005-04-13 | Merck Sharp & Dohme | Therapeutic agents |
| GB0505437D0 (en) | 2005-03-17 | 2005-04-20 | Merck Sharp & Dohme | Therapeutic agents |
| GB0505725D0 (en) | 2005-03-19 | 2005-04-27 | Merck Sharp & Dohme | Therapeutic agents |
| TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| US7494998B2 (en) | 2005-04-26 | 2009-02-24 | Hypnion, Inc. | Benzisoxazole piperazine compounds and methods of use thereof |
| EP1734039A1 (en) | 2005-06-13 | 2006-12-20 | Esbatech AG | Aryl urea compounds as BETA-secretase inhibitors |
| EP1910307A1 (en) | 2005-06-27 | 2008-04-16 | Exelixis, Inc. | Pyrazole based lxr modulators |
| US8093401B2 (en) | 2005-08-04 | 2012-01-10 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| TWI329641B (en) | 2005-08-31 | 2010-09-01 | Otsuka Pharma Co Ltd | (benzo[b]thiophen-4-yl)piperazine compounds, pharmaceutical compositions comprising the same, uses of the same and processes for preparing the same |
| WO2007120600A2 (en) | 2006-04-10 | 2007-10-25 | Arena Pharmaceuticals, Inc. | 3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| GB0608655D0 (en) | 2006-05-03 | 2006-06-14 | Merck Sharp & Dohme | Therapeutic Treatment |
| EP2018371B1 (en) | 2006-05-18 | 2015-03-04 | Arena Pharmaceuticals, Inc. | Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| CN102827081A (zh) | 2006-05-18 | 2012-12-19 | 艾尼纳制药公司 | 用作5-ht2a 血清素受体调节剂的苯基-吡唑的晶型和其制备方法 |
| EP2027119A2 (en) * | 2006-05-18 | 2009-02-25 | Arena Pharmaceuticals, Inc. | Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| JP2009537556A (ja) | 2006-05-18 | 2009-10-29 | アリーナ ファーマシューティカルズ, インコーポレイテッド | 5−ht2aセロトニンレセプターに関連する障害の処置に有用な5−ht2aセロトニンレセプターのモジュレーターとしてのアセトアミド誘導体 |
| JP2010502618A (ja) | 2006-08-31 | 2010-01-28 | アリーナ ファーマシューティカルズ, インコーポレイテッド | セロトニン5−ht2a受容体のモジュレータとしてのベンゾフラン誘導体 |
| TWI415845B (zh) | 2006-10-03 | 2013-11-21 | Arena Pharm Inc | 用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物 |
| WO2008054748A2 (en) | 2006-10-31 | 2008-05-08 | Arena Pharmaceuticals, Inc. | Indazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| EP2190844B3 (en) | 2007-08-15 | 2013-07-17 | Arena Pharmaceuticals, Inc. | Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| JP2009196349A (ja) | 2008-01-25 | 2009-09-03 | Canon Finetech Inc | バーコード印刷装置およびバーコード印刷方法 |
| WO2011075596A1 (en) | 2009-12-18 | 2011-06-23 | Arena Pharmaceuticals, Inc. | Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
-
2007
- 2007-05-17 EP EP07777120.2A patent/EP2018371B1/en active Active
- 2007-05-17 US US14/091,946 patent/USRE45336E1/en active Active
- 2007-05-17 ES ES07777120.2T patent/ES2536762T3/es active Active
- 2007-05-17 WO PCT/US2007/011834 patent/WO2007136703A1/en not_active Ceased
- 2007-05-17 JP JP2009511067A patent/JP5406018B2/ja not_active Expired - Fee Related
- 2007-05-17 US US12/301,172 patent/US8148417B2/en not_active Ceased
-
2012
- 2012-03-09 US US13/417,028 patent/US8664258B2/en active Active
-
2014
- 2014-01-28 US US14/166,511 patent/US9328107B2/en active Active
-
2015
- 2015-02-27 US US14/634,218 patent/US20150265576A1/en not_active Abandoned
-
2016
- 2016-08-15 US US15/236,722 patent/US9987252B2/en active Active
-
2018
- 2018-04-26 US US15/963,635 patent/US20190070149A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009537545A5 (OSRAM) | ||
| CN101492416B (zh) | 影响葡糖激酶的化合物 | |
| CN100427469C (zh) | 作为嗜中性白细胞弹性蛋白酶抑制剂的喹啉衍生物及它们的用途 | |
| JP5216341B2 (ja) | 血管新生阻害活性を有する新規オキサジアゾール誘導体およびチアジアゾール誘導体 | |
| JP2006523721A (ja) | Jnk阻害剤としてのインダゾール誘導体 | |
| WO2004103980A1 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i | |
| US9580438B2 (en) | Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders | |
| RU2312105C9 (ru) | N-пиразинилфенилсульфонамиды и их применение при лечении опосредованных хемокинами заболеваний | |
| CA2337588A1 (en) | Oxamides as impdh inhibitors | |
| WO2004043924A1 (en) | 2-pyridone derivatives as inhibitors of neutrophile elastase | |
| JP2013517273A5 (OSRAM) | ||
| EP1313711A2 (en) | Indazole derivatives as jnk inhibitors | |
| JP2008516974A5 (OSRAM) | ||
| IL173990A (en) | Derivatives of 2-pyridone as neutrophil elastase inhibitors and their use | |
| JP2011517458A5 (OSRAM) | ||
| JP2008509982A (ja) | アリール尿素誘導体 | |
| JP2007531752A5 (OSRAM) | ||
| CA2583742A1 (en) | 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists | |
| JP2009537543A5 (OSRAM) | ||
| SK10197A3 (en) | Aromatic amino ethers, preparation methods thereof and pharmaceutical agents containing them | |
| JP2008524244A5 (OSRAM) | ||
| EP2702043A1 (en) | Inhibitors of inducible form of 6-phosphofructose-2-kinase | |
| JP2004532227A5 (OSRAM) | ||
| CN101643458A (zh) | 在疼痛的治疗中用作钠或钙通道阻断剂的杂芳基氨基磺酰基苯基衍生物 | |
| CA2582276A1 (en) | Alkil-pyridines as 11-beta inhibitors for diabetes |